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A dynamic model for the growth of Salmonella spp. in liquid whole egg under 
continuously varying temperature was developed and validated. A primary model 
(Baranyi model) was fitted to each temperature growth data and corresponding maximum 
growth rates were estimated. Pseudo-R
2
 values were greater than 0.97 for primary 
models. The maximum growth rates obtained from each primary model were then plotted 
against temperature and modeled using the modified Ratkowsky model. The pseudo-R2 
and root mean square error were 0.99 and 0.06 h
-1
, respectively for the secondary model. 
A dynamic model for the prediction of Salmonella spp. growth under varying 
temperature conditions was developed by solving a combination of primary and 
secondary models using fourth-order Runga-Kutta method. The developed dynamic 
model was validated for two sinusoidal temperature profiles, 5-15
o
C and 10-40
o
C with 
corresponding RMSE values of 0.28 and 0.23 log CFU/ml, respectively between 
predicted and observed values. The developed dynamic model can be used to predict the 
growth of Salmonella spp. in liquid whole egg under varying temperature conditions. 
The germination and outgrowth of B. cereus and C. perfringens spores during the egg 
white hydrolysate (EWH) manufacturing process was evaluated. EWH was prepared by 
enzymatic hydrolysis of the inoculated egg white solution and maintained at optimum pH 
for enzymes (trypsin and chymotrypsin) for 24 h at 37
o
C. B. cereus population was 
increased by > 3.5 log CFU/ml during the EWH preparation using chymotrypsin, while 
minimal increase was observed during trypsin hydrolysis. C. perfringens populations 
were reduced during EWH preparation irrespective of the enzyme used. Hydrolysis of 
major egg proteins by chymotrypsin was completed within 4 h of incubation, while 
minimal hydrolysis of egg white proteins was observed with trypsin subsequent to 24 h 
incubation. New enzymes other than trypsin and chymotrypsin should be exploited for 
manufacturing egg white hydrolysates. 
Keywords: Salmonella, B. cereus, C. perfringens, egg, hydrolysates, predictive modeling
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THESIS FORMAT 
 
This thesis consists of four chapters. Chapter 1 is the introduction and literature review 
for Salmonella spp. in liquid whole egg along with the information about models used in 
predictive microbiology. Chapter 2 is written as a technical journal article for publication 
and describes a predictive model for the growth of Salmonella spp. in liquid whole egg 
under non-isothermal conditions. Chapter 3 is the introduction and literature review of 
egg white hydrolysates manufacturing process and information regarding bacterial 
spores. It also discuss about different peptides obtained from food protein hydrolysis. 
Chapter 4 again is written as a technical journal article for publication and provides a risk 
evaluation of egg white hydrolysates manufacturing process.  
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INTRODUCTION 
 
Foodborne illnesses affect people and society economically around the world (WHO, 
2002). The United States Centers for Disease Control and Prevention (CDC) estimated 76 
million cases, 300,000 hospitalizations and 5,000 mortalities from foodborne illnesses 
annually (Mead et al., 1999). There is a need to systematically evaluate the risk of food 
manufacturing processes to control, reduce and/or eliminate the food safety hazards for 
improving the safety of food supply. Egg and egg products are used widely in food 
preparation and approximately 900 food products contain eggs or egg components (AEB, 
2007). Eggs can be contaminated with Salmonella spp. before laying as well as 
subsequent to laying. Potential sources of egg contamination include air, wash water, soil, 
equipment, cross contamination, and the food handlers (AEB, 2007). A majority (> 90%) 
of the foodborne illnesses are caused by improper storage, handling, or cooking of food 
(FSIS, 2006). In most cases, temperature abuse of contaminated raw materials and 
absence of a step in the food chain which can reduce and/or eliminate the microorganisms 
can result in proliferation of the foodborne pathogens, increasing the potential risk of 
foodborne illness. Salmonella spp. is the most commonly associated pathogen with egg 
and egg products. It is estimated that salmonellosis affects 1.3 million people in the 
United States annually (CDC, 2003). Temperature abuse of shell eggs during collection, 
storage and processing may create favorable conditions for the growth of Salmonella spp. 
The USDA Food Safety and Inspection Service (FSIS) published a risk assessment of 
Salmonella spp. in shell eggs and liquid egg products (FSIS, 2005) and identified several 
research needs to improve the existing risk assessment model. The overall objective of 
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this study was to develop models to predict the growth of Salmonella spp. in liquid whole 
egg under non-isothermal conditions. The specific objective of the study was to develop 
and validate a dynamic model to predict the growth of Salmonella spp. in liquid whole 
egg under non-isothermal conditions. 
LITERATURE REVIEW 
Microorganism 
 Salmonella spp. 
  
 Salmonella is a rod-shaped, Gram negative, motile (few non-motile exceptions), non 
spore forming, facultatively anaerobic bacterium. The prevalence of Salmonella spp. is 
high in animals and animal products, especially poultry and swine. Sources of 
contamination include water, soil, insects, kitchen surfaces, cross contamination, animal 
feces, raw meats, raw poultry including eggs, and raw sea foods (FDA-CFSAN, 2006). 
Salmonella spp. can grow at temperatures ranging from 5.3°C to 46.2°C (Matches and 
Liston, 1968), with an optimum between 35°C and 37°C. Salmonella spp. is not salt 
tolerant and salt (NaCl) concentrations of 3-4% are inhibitory to its growth. Salmonella 
can grow between pH 4.5 to 9.0 with an optimum pH of 6.5-7.5.  
Over 2,500 Salmonella serovars have been identified and are categorized into two 
species; Salmonella enterica and Salmonella bongori (Janda, 1998). Majority of serovars 
belong to Salmonella enterica and are further sub–categorized into five subtypes. The O 
antigen is used to classify the serovars into groups A, B, C1, C2, D, and E1, based on the 
similarities and differences of specific O antigens.  
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Salmonellosis 
 
The symptoms of salmonellosis include diarrhea, abdominal cramps, nausea, vomiting, 
fever, and headache. The onset of symptoms begins within 6 to 72 h after the 
consumption of food and can last from 4 to 7 days. The symptoms are usually resolved 
without antibiotic treatment in healthy individuals. However, the bacteria can enter the 
blood stream, leading to a severely fatal illness. The invasive, life–threatening form of the 
disease is more likely to occur in highly susceptible populations, including children, 
elderly, and the immunocompromised (Gordon, 2008). Salmonella eneirica serovar 
Enteritidis (SE) was found to cause greater proportion of foodborne illnesses compared to 
other serotypes (CDC, 1996). SE related outbreaks between the years 1985 and 1995 
accounted for 24,058 cases of illness, 2,290 hospitalizations, and 70 deaths (MMWR, 
1996). A gradual increase of SE infections occurred from 1976 to 1995, with slight 
reductions by 1999. However, the number of illnesses and outbreaks remained stable 
since 2001 (MMWR, 2003), with an estimated number of cases alone involving human  
SE is 200,000 to 1 million annually in the U.S. (Morales and McDowell, 1999).  
 Salmonella Entry into the Eggs 
 
Eggs internally contaminated with SE were the leading cause of foodborne illness during 
past two decades (MMWR, 2003). A farm-to-table risk assessment of shell eggs and egg 
products by FSIS, FDA and CDC estimated that 2.3 million shell eggs in the U.S. are 
contaminated with SE when laid (USDA-FSIS, 1998). Undercooked and raw shell eggs 
and their products are the most common sources of Salmonella spp. infection (MMWR, 
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2003). SE introduced in chicken either naturally or experimentally resulted in 
contamination of the egg‟s liquid interior with a few hundred SE cells in the freshly laid 
eggs (Humphrey et al., 1991; Gast and Holt, 2000a; Chen et al., 2002). Refrigeration of 
eggs to an internal temperature of <7.2
o
C can inhibit the growth of SE and lower the 
potential for human exposure and thus, the risk of illness. The location of Salmonella spp. 
in egg contents is an important factor for the potential growth of organism. Salmonella 
spp. can colonize the reproductive tract of the hen, resulting in an entrapment of SE in the 
egg albumen or yolk during formation of the egg (Humphrey et al., 1989; Gast and 
Beard, 1990; Humphrey et al., 1991; Gast and Holt, 2000b). Gast and Holt (2001) 
reported that contamination of Salmonella spp. is mostly on the yolk membrane, rather 
than the interior of the yolk. Salmonella spp. can survive, but cannot grow in albumen 
due to higher pH and other inhibitory factors in albumen (Baron et al., 1997; Gast and 
Holt, 2000b). On the contrary, yolk is a nutrient rich medium, and rapid growth of 
Salmonella spp. is possible at storage temperatures above 20oC (Bradshaw et al., 1990; 
Humphrey and Whitehead, 1993; Braun and Fehlhaber, 1995; Gast and Holt, 2000b). 
Gast and Holt (2001) reported that Salmonella spp. can penetrate the yolk through the 
yolk membrane and then multiply. Rapid refrigeration is necessary to prevent bacterial 
penetration into the yolk and further proliferation. Jones et al. (2004) reported that SE 
population in the interior egg contents increased during storage of SE inoculated eggs at 
room temperature for 5 weeks and demonstrated that SE growth can take place in the 
yolk during cooling of the egg subsequent to lay.  
Egg Tempering Step 
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The egg tempering step is usually invoved before breaking of eggs. The objective of 
tempering the eggs is fine separation of egg yolk and egg white from shell eggs. During 
this step the eggs are stored in rooms having temperatures > 7.2
o
C where Salmonella spp. 
present in egg products can proliferate and increase to higher numbers. The tempering of 
shell eggs can be for 2 to 3 days in some cases which can result in substantial amount of 
increase in Salmonella counts if present initially 
Regulatory Issues 
 
The CDC reported a decrease in Salmonella prevalence by 9%, probably due to the 
decrease in incidences of S. Typhimurium (which decreased 42% in 2005 compared to 
1996-1998). The estimated prevalence of SE (25%), S. Heidelberg (25%) and S. Javiana 
(82%) have increased significantly during the same time period (CDC, 2006). The CDC 
reported that Salmonella serotypes Typhimurium, Enteritidis, Newport, Heidelberg and 
Javiana accounted for 61% of the total isolates and SE as the second leading serotype 
causing human illnesses (CDC, 2006). The risk assessment for SE in eggs and egg 
products indicated that multiple interventions are required in farm-to-table chain to 
reduce the risk of illnesses from SE (FDA, 1997). The FDA proposed transportation and 
storage of eggs < 7.2
o
C as mandatory temperature to prevent the rapid multiplication of 
SE in contaminated eggs. Subsequently, FSIS (1998) mandated transportaion and storage 
of eggs at < 7.2
o
C. However, cooling of eggs can be slow and may require several days to 
reach this specific internal egg temperature to restrict bacterial growth in the commercial 
processing operations (Curtis et al., 1995; Thompson et al., 2000).  
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Predictive Microbiology 
 
Predictive Modeling 
 
Growth of microorganisms in foods is affected by both intrinsic and extrinsic factors such 
as temperature, pH, sodium nitrite, sodium chloride, water activity, antimicrobials, and 
modified atmosphere packaging conditions (McKeller, 1997; Juneja, 2003; Malakar et 
al., 2003; Schultze et al., 2006). Understanding of parameters governing growth of 
pathogens in food can be useful in determining their survival, growth and behavior in 
foods and in controlling their proliferation. Factors responsible for microbial growth can 
be effectively studied with the help of predictive models (Francois et al., 2006; Schultze 
et al., 2006). Predictive microbiology use a combination of mathematical, statistical and 
microbiological principles to quantitatively predict the behavior of microbial populations 
in foods (Ross et al., 2000). A number of mathematical functions have been proposed to 
describe the sigmoid curves, and have been used to model the batch growth of microbial 
cultures (McMeekin et al., 2008). The Pathogen Modeling Program (PMP), developed by 
USDA Agriculture Research Service has growth models for Salmonella spp., Listeria 
monocytogenes, Escherichia coli O157:H7, Bacillus cereus, Staphylococcus aureus, C. 
perfringens, and Shigella flexneri under different environmental conditions. The 
predictive models can be used by food industry to evaluate the risk of pathogen growth or 
control to minimize the risk of foodborne illness. Food processing facilities use variable 
temperatures during processing which in turn affect the microbial growth. Dynamic 
models that can predict microbial growth under variable temperature conditions are 
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developed by integrating primary and secondary models. Primary models can be obtained 
by growth data of pathogens under a constant environment such as temperature over time. 
Secondary models describe the effect of environmental conditions on the parameters of 
primary models. Finally, both primary and secondary models can be integrated to develop 
dynamic models. 
Primary Models 
 
The microbial growth curve can be divided into four phases viz. lag, logarithmic, 
stationary and death. The first three phases are of much interest for food microbiologists. 
Under isothermal conditions, researchers use sigmoid functions to fit the growth curve of 
microorganisms (Amézquita, 2004). Common primary models are:  
(i) Gompertz Model 
   
*( ) exp expN t C A B t M  ……………………………... (1.1) 
where, C represents the value of the lower asymptote with units of log10 (CFU/g or ml), 
the parameter A* is the asymptotic term (log10), the parameter M corresponds to the time 
at which the slope of the sigmoidal growth reaches a maximum value and the parameter 
B is the maximum growth rate relative to the amount of growth at time (t). 
 
(ii) Modified Gompertz and Logistic models (Gibson et al., 1987, 1988) 
Modified Gompertz model is given by equation 
                  ……….……………… (1.2) 
and the logistic equation (Gibson et al., 1987, 1988) 
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     ……………………………...………………… (1.3) 
The modified Gompertz and logistic models contain the same parameters: L(t) is the log 
(CFU/mL) of cell concentration; A and B are the initial and final cell concentrations; t the 
growth time;  =  (h
-1
); and , the inflection point of the slope (h), and  is 
the maximum specific growth rate (h
-1
). 
(iii)     Baranyi Model 
A model developed by Baranyi et al. (1993, 1994, 1995a, 1995b) is being frequently used 
for modeling microbial growth in temperature varying conditions. Baranyi et al. (1993, 
1994, 1995a, 1995b) have used the term “bottleneck substance” meaning a critical 
substance  that the cells needs in order to adjust to their new environment and reach 
the exponential phase. The development of the critical substance, q, follows first order 
kinetics and has a constant specific rate of v, which is assumed to be equal to  of the 
bacterial culture. The process of adjustment of the cells to their new environment can be 
described by 
                  ……………………………………………………………... (1.4) 
This process of adjustment (lag period) is characterized by the gradual increase of  
from a low value towards 1 (Baranyi and Roberts, 1994). Another transformation: 
                ……………………………………… (1.5) 
is calculated by the product of the lag period, , and the maximum specific growth 
rate.  is constant for the different growth curves provided that the physiological state of 
the cells at inoculation is identical., Generally, the lag period and growth rates are 
18 
 
modeled independently despite the high correlation between them. The models of 
Baranyi et al. (1993, 1994, 1995a, 1995b) allow these two parameters to be modeled 
together and the model is made applicable to a time-dependent environment. 
Because of the transition from the exponential to the stationary phase, a logistic-type 
limiting function is applied to the cell concentration (Baranyi et al., 1995): 
…………………………………………… (1.6) 
with initial values of  and , where x is the cell concentration, and 
………………………………………………………… (1.7)  
with initial conditions of  and . 
If  is the natural logarithm of the cell concentration and if in a constant environment 
(isothermal conditions), the solution to the above system is 
…………..………………. (1.8) 
where , , and 
                  …………………………… (1.9) 
Under the assumption that the critical substance grows at the same specific rate as the 
cells in the exponential phase, , resulting in four parameters in Baranyi‟s 
model: , , , and . Figure 1.1 shows these parameters and how they are 
calculated from the growth profiles. 
This primary model can be used to predict the growth of microorganisms under 
isothermal conditions.  is a function of time, while  is a function of temperature 
which is also a function of time.  
19 
 
 
 
 
Figure 1.1. Parameters associated with Baranyi‟s growth model. Parameters  and  
are the initial and maximum growth, respectively (logeCFU/mL),  is the maximum 
specific growth rate (h
-1
) and . 
 
Secondary Models 
 
Secondary models are used to model the impact of environmental conditions, such as 
temperature, pH, water activity and factors responsible for bacteria growth on the values 
of the parameters of a primary model (McKellar, 1997). Maximum specific growth rate 
max  and the lag time  are two most important parameters in modeling of bacteria. 
(i) Square-Root Models 
Ratkowsky et al. (1983) proposed a square root relationship between temperature and 
maximum specific growth rate. 
20 
 
                   max minK K
b T T
...………………………………………………... (1.10)
  
where, b  is a regression coefficient and is equivalent to the slope of the regression line 
with units of 1 1 2K h , and the parameter minKT  is the theoretical minimum temperature 
for growth, with units of K. The parameter 
minKT  is the intercept of the predicted function 
and the temperature axis. 
(ii)     Modified Ratkowsky’s equation and Gamma equation 
The modified Ratkowsky‟s equation (Zwietering et al., 1991), 
                 ………………………... (1.11) 
in which c  (with units of 1K ) and 
maxKT  (with units of K), are parameters to be 
estimated, b and c are Ratkowsky parameters. 
Gamma equation (Rosso et al., 1993), 
                ………………………………………………...... (1.12) 
where,  …………...(1.13) 
each contain four parameters: , optimum maximum specific growth rate (h
-1
); , 
optimum temperature (°C); , theoretical minimum temperature (°C); and , 
theoretical maximum temperature (°C). 
Dynamic models 
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The differential forms of the primary models which allow for prediction under non-
isothermal conditions can be solved using numerical methods. A common method to 
solve first order differential equations in the form 
……………………………………………….. (1.14) 
 is the fourth order Runge-Kutta method (Kam, 2006). This algorithm discretizes the time 
domain as 
,  for    ………………………….. (1.15) 
and evaluates the function  at the beginning, end, and midpoint of each time 
interval (Amézquita, 2004). All the Runge-Kutta methods have algorithms of the form 
 ………………………………………………. (1.16) 
with  as the increment function that is a chosen approximation to  on the interval 
 (Carnahan et al., 1969). Letting  be a weighted average of four derivative 
evaluations k1, k2, k3, and k4 on the interval  results in the Runge-Kutta 4
th
 
order algorithm 
…………...……………. (1.17) 
Knowing the value of  at , the value of  at  and  can 
be found and Equation (1.14) is equated to the first five terms of Taylor series (Kam, 
2006) 
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………………………………… (1.18) 
Knowing that  and , 
.. 
(1.19) 
and a popular solution to Equations (1.15) and (1.16) is 
……………………………….. (1.20) 
…………………………………………………….. (1.21) 
……………………………………... (1.22) 
……………………………………. (1.23) 
…………………………………………. (1.24) 
(Amézquita, 2004 and Kam, 2006).  
The differential equations of Baranyi, Gompertz, and Logistic models can be solved 
using the Runge-Kutta 4
th
 order algorithm. These differential equations are integrated 
with a specific secondary model and then can be used to predict growth over time for 
non-isothermal profiles. 
Salmonella spp. growth in egg 
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Egg shells can often be contaminated with Salmonella spp. and other bacteria. The 
surface contamination can translocate to the interior of eggs. Grijspeerdt (2001) described 
a model for the penetration of surface contamination to the interior of eggs. The 
movement of motile bacteria inside egg was found to be based on diffusion and a first-
order linear movement. Other study involved the effect of immunization of hens on the 
growth of SE in yolk (Gurtler and Fehlhaber, 2004) where hens were immunized with 
SE. The eggs were collected and the SE populations were determined. Schoeni et al. 
(1995) reported that regardless of the initial inoculums size, 10
2
 or 10
4 CFU/g in yolk or 
albumen, populations of all Salmonella serovars increased by > 3 logs in 24 h at 25°C. 
Gast and Holt (2000b) reported that rapid growth of SE at 25oC when the Salmonella spp. 
reached closer to the yolk with storage (2 or 3 days). Lower inoculum size, shorter 
storage resulted in a slower growth of SE. The growth of Salmonella spp. or SE in 
albumen was either slower or resulted in reduced cell population (Schoeni et al., 1995; 
Gast and Holt, 2000b; Messens et al., 2004; Grijspeerdt et al., 2005). Whiting and 
Buchanan (1997) reported that pasteurization provided sufficient consumer protection 
from SE contamination of eggs. However, certain cases of inadequate pasteurization 
and/or temperature abuse during storage can lead to a hazardous, contaminated product. 
Gumudavelli et al. (2007) developed a dynamic model for the growth of SE in egg yolk 
using Barayni model and modified Ratkowsky‟s equation for fitting primary and 
secondary models, respectively. The current USDA-FSIS guidelines for pasteurization of 
liquid whole egg product (3.5 min at 60°C) results in an estimated 5.9 log CFU/g 
reduction in Salmonella spp. (USDA-FSIS, 2006). The cumulative prevalence rates (from 
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1995 through 2008) per 100 g of whole eggs or yolks (with < 2% of added ingredients 
other than salt or sugar), whole eggs with added yolks or whole egg blends (with >2% 
salt or sugar added) were 0.28, 0.27, and 0.62%, respectively (USDA-FSIS, 2009). The 
prevalence rates for the same products in 2008 were 0.45, 0.00, and 0.29%, respectively. 
These data indicate that either the product is recontaminated subsequent to pasteurization 
or the levels of Salmonella spp. prior to pasteurization were higher than the performance 
standard required for pasteurization. Regardless, the prevalence of Salmonella spp. 
subsequent to pasteurization requires the processors to refrigerate the product subsequent  
to pasteurization to minimize its growth. While the egg product processors can set critical 
limits for the temperature of storage of these products, it is possible that process 
deviations can occur. In such cases, the processors need a tool to evaluate the potential 
risk of Salmonella spp. growth and the subsequent risk of foodborne illness. The 
developed dynamic model for Salmonella spp. growth in liquid whole egg will be useful 
for the processors to set critical limits within their HACCP plans or to evaluate the 
potential risk of Salmonella spp. growth during process deviations. The objective of the 
current study was the development of dynamic model that can predict the growth of 
Salmonella spp. under varying temperature conditions and hence can be used to mitigate 
Salmonella spp. risk from egg and egg products. 
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ABSTRACT  
 
A dynamic model for the growth of Salmonella spp. in liquid whole egg under 
continuously varying temperature was developed and validated. Liquid whole egg was 
inoculated with ca. 2.5-3.0 log CFU/ml of Salmonella spp. to obtain the growth data at 
several isothermal conditions (5, 7, 10, 15, 20, 25, 30, 35, 37, 39, 41, 43, 45 and 47
o
C). A 
primary model (Baranyi model) was fitted for each temperature growth data and 
corresponding maximum growth rates were estimated. Pseudo-R
2
 values were greater 
than 0.97 for primary models. The maximum growth rates obtained from each primary 
model were then plotted against temperature and modeled using the modified Ratkowsky 
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model. The pseudo-R
2 
and root mean square error was 0.99 and 0.06 log CFU/g, 
respectively for the secondary model. A dynamic model for the prediction of Salmonella 
spp. growth under varying temperature conditions was developed by solving a 
combination of primary and secondary models using fourth-order Runga-Kutta method. 
The developed dynamic model was validated for two sinusoidal temperature profiles, 5-
15
o
C and 10-40
o
C with corresponding RMSE values of 0.28 and 0.23 h
-1
, respectively 
between predicted and observed values. The developed dynamic model can be used to 
predict the growth of Salmonella spp. in liquid whole egg under varying temperature 
conditions. 
Keywords: predictive model, Salmonella, whole egg, dynamic 
INTRODUCTION 
 
Egg and egg products are used extensively as ingredients in food products and 
approximately 45 % of the eggs are further processed (United Egg Producers, 2009). An 
estimated 209 million cases of eggs are produced in the U.S. with a per capita 
consumption of 249 eggs (United Egg Producers, 2009). The eggs are collected and 
stored for transportation, subsequently increasing the time between collection and 
processing. In most cases, shell eggs are transferred from the laying house to the egg 
packaging plant by conveyers or manually. The eggs are subsequently cleaned and 
packed in cartons and palletized. The pallets are placed in refrigerated rooms set at 7
o
C 
(Keener et al., 2000). The USDA-FSIS proposed 7.2
o
C as a mandatory temperature for 
transportation and storage of eggs in the retail market. Sometimes, it may take up to 7 to 
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10 days for the eggs to reach 7
o
C from an initial temperature of 25 to 30
o
C (Anderson et 
al., 1992). In the United States, most eggs are sold after approx. 19 days of laying with an 
average sell by date of approx. 30 days (Bell et al., 2001; Patterson et al., 2001). Thus, 
the eggs undergo continuous temperature fluctuations, from the time they are laid to the 
time of processing. These temperature fluctuations can result in penetration and growth 
of Salmonella spp. from the shell surface or SE growth within the egg if the egg contents 
are contaminated. 
Mathematical models describe the behavior of microorganisms under the influence of 
various environmental factors. Predictive models are economical and convenient for 
evaluating microbial growth compared to traditional laboratory microbiological testing. 
The USDA-FSIS risk assessment of Salmonella spp. in shell eggs and egg products stated 
that available data for estimating growth parameters and complete growth data of 
Salmonella spp. suitable for predictive models are lacking (FSIS, 2005). The objective of 
this research was to develop and validate a predictive model of Salmonella spp. growth in 
liquid whole egg under varying temperature conditions.  
MATERIALS AND METHODS 
 
Preparation of Liquid Whole egg 
 
Fresh shell eggs (< 1 day after lay) were collected from the University of Nebraska, 
Lincoln poultry farm. Selected eggs free from blood spots were washed with warm water 
to remove external visible contamination. The eggs were sanitized by dipping in ethanol 
(70%) for 15 min and allowed to dry. Shell eggs were broken in a sterile bio safety 
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cabinet (Bellco Glass Inc., Vineland, NJ) with an alcohol sanitized knife. Egg albumen 
and yolk were separated aseptically and collected in sterile containers. Yolk and albumen 
were blended separately using a Waring blender (Blender; Waring Commercial 
Laboratory Blender, New Hartford, CT) attached to a rheostat (Superior Electric Co., 
Bristol, CT) set at 20-35 rpm and 120 v.  
Total Solids and pH adjustment 
 
Total solids of the yolk and albumen were estimated following AOAC methods (AOAC, 
1970). The required quantities of yolk and albumen were mixed to obtain liquid whole 
egg of 24% total solids. The pH of the liquid whole egg was measured using pH meter 
(Model Accumet Basic/AB15, Fisher Scientific, Pitttsburgh, PA) and adjusted to 7.8 
using 1N NaOH or 1N HCl.  
Bacterial Cultures 
 
Five serovars (Enteritidis phage types 4 and 13, Typhimurium TM-1, Blockley, and 
Heidelberg) of Salmonella were used. The stock culture of each serovar was thawed 
under refrigeration and three subsequent transfers were made in 10 ml tryptic soy broth 
(TSB; BD Bacto, Sparks, MD) and incubated for 16-18 h at 35°C. A 2 ml aliquot of each 
serovar was transferred aseptically to a sterile centrifuge tube and centrifuged at 6,000 x 
g for 10 min at 4°C (Beckman GS-15R, Fullerton, CA). The supernatant was discarded 
and the bacterial cell pellet was reconstituted in 10 ml of 0.1% sterile peptone water (PW; 
BD Difco, Sparks, MD) and serially diluted (1:10) in PW to obtain appropriate 
concentrations for inoculation. 
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Sample Inoculation 
 
Appropriate volume of the five serovar cocktail of Salmonella spp. was added to liquid 
whole egg to obtain ca. 2.5-3 log CFU/ml of Salmonella spp and blended for 1 min. 
Portions (5ml) of the inoculated liquid whole egg were transferred to vacuum pouches 
(6.35 cm x 12.7 cm; Prime Source, Kansas City, MO; 3 mil standard barrier nylon pouch, 
oxygen transmission rate of 3,000 cm
3
/m
2
/24 h at 23°C and 1 atm) and were heat sealed. 
Isothermal and Dynamic Profiles 
 
Salmonella growth data was collected at isothermal temperatures of 5, 7, 10, 15, 20, 25, 
30, 35, 37, 39, 41, 43, 45 and 47°C to cover the entire bio-kinetic growth temperatures 
and also for the two sinusoidal heating-cooling profiles (5-15°C and 10-40°C). For both 
isothermal and sinusoidal profiles, Salmonella spp. population was determined until 
stationary phase was reached. Programmable water baths with water circulation 
capabilities (RTE 740, Thermo Neslab, Portsmouth, NH) were used to follow the 
temperature profiles. A commercial software package (NesCom Software, Portsmouth, 
NH) was used to program the temperature profiles in the water baths. The pouches 
containing inoculated product were immersed in water baths maintained at constant 
temperatures for isothermal profiles and in programmable water baths for sinusoidal 
profiles mentioned above. A pouch was removed after 10 min equilibration time and the 
initial Salmonella spp. was determined. Remaining pouches were removed at specific 
intervals until 2 to 3 points in stationary phase of Salmonella were attained at each 
profile. 
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Microbial Enumeration 
 
The pouches were removed from the water bath at predetermined intervals and massaged 
for 2 min to uniformly mix the contents of pouch. Surfaces of the pouches were sprayed 
with alcohol, wiped with paper towel and aseptically opened. Appropriate dilutions of the 
sample were prepared in PW and either spread or spiral plated on xylose lysine 
deoxycholate (XLD) agar (Difco) for all profiles. Both XLD and tryptic soy agar (TSA) 
were used for enumeration of Salmonella spp. for temperature profiles above 35oC to 
evaluate microbial injury. XLD and TSA plates were incubated at 35°C for 24 and 48 h, 
respectively. Typical colonies were counted and microbial populations expressed as log 
CFU/ml. 
Modeling 
Primary Model 
 
Dynamic model (Baranyi and Roberts, 1994) includes a set of differential equations (Eq. 
2.1a and 2.b) for predicting the growth of microorganisms under time-varying 
temperature conditions. 
max
max
1
1
1
y y
Q
dy
e
dt e
 ......................................................................... (2.1a) 
max
dQ
dt
....................................................................................................... (2.1b) 
with initial conditions y = yo at t = 0 and Q = loge(qo) where q is a measure of the initial 
physiological state of cells. 
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The four-parameter Baranyi model obtained by analytically solving above two equations 
was used for bacterial growth at isothermal conditions (Baranyi and Roberts, 1994): 
max
max 0
( )
0 max e
1
( ) ( ) log 1
F t
y y
e
y t y F t
e
........................................................... (2.2) 
where 00
e
1
( ) log
vt hhvtF t t e e e
v
 
y(t) is logeCFU/g of cell concentration at time, t 
yo is initial cell concentration in logeCFU/ml; ymax is maximum cell concentration 
in logeCFU/ml  
µmax is maximum specific growth rate in terms of logeCFU/ml in 1/h 
ν is rate of increase of the limiting substrate, assumed to be equal to µmax 
 h0 is equal to µmax*λ; λ is lag-phase duration in h.  
Analysis of results and fitting of the model to growth data were done in loge CFU/ml 
units and the results were reported in log10 CFU/ml. 
Growth data (selective medium) obtained from each isothermal profile was plotted 
against time and the starting values of parameters (y0, h0, µmax and ymax) were estimated. 
The value of the lower asymptote and upper asymptote were given as starting values for 
y0 and ymax, respectively. Slope of exponential phase of bacterial count with respect to 
time was considered as starting value of the maximum growth rate (µmax). The starting 
value for h0 is calculated by multiplying the maximum growth rate (µmax) by lag time (λ). 
The lag time is the time difference between starting up of profile and exponential growth.  
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A nonlinear regression procedure, PROC NLIN, in SAS package (SAS, 2006) was used 
to fit the data to the models with the Marquardt iterative method for estimation of 
parameters (SAS programs are given in Appendix A.1 and A.2). The given starting 
values were converged to estimate values the parameters (before fixing) after several 
iterations using the nonlinear procedure. Baranyi and Roberts (1994) suggested that in 
situations where the pre-inoculation history of the cells is identical, the value of h0 is 
approximately constant. The h0 value was fixed at the average value of h0 estimated for 
all the temperatures and the observed data were again fitted at fixed h0 using the model to 
estimate the other three parameters (after fixing parameters).  
In nonlinear regression, R
2
 value should not be used for deriving conclusions like linear 
regression. Therefore, pseudo-R
2
 (Eq. 2.3) defined by Schabenberger (2005) was used to 
evaluate the goodness of fit. 
 2 1
SSR
Pseudo R
TSS
...................................................................................... (2.3) 
where SSR is sum of squares of residuals and TSS is total sum of squares. 
Root Mean Squared Error (RMSE) (Eq. 2.4) was also used to evaluate the model 
performance.                                        
pN
PO
RMSE
2)(
 ....................................................................................... 
(2.4) 
where O and P are observed and predicted microbial populations in log10 CFU/g, N is the 
number of observation, and p is the number of model parameters. The above two 
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statistics were calculated for each temperature after fitting the observed growth data into 
the Baranyi model.  
Secondary Model 
 
The modified Ratkowsky equation was used as secondary model equation in present 
study to describe the effect of temperature on growth rate, as described by (Zwietering et 
al., 1991): 
µmax = 
2
min max( ) (1 exp( ( )))a T T b T T  ............................................................... (2.5) 
Tmin - theoretical minimum temperatures beyond which growth of the organism is not 
possible. Starting value was given 7
o
C.  
Tmax - theoretical maximum temperatures beyond which growth of the organism is not 
possible. Starting value was given 45
o
C. 
a and b are regression coefficients.  
The starting value of parameter “a” was determined by calculating the slope when 
max
 
values were plotted against T until the optimum growth rate occurred (Eq. 2.5).  
 max min( )a T T ............................................................................................ (2.6) 
Starting value for b regression coefficient was taken as 1. 
The first term in Equation (2.5) describes the growth rate up to the optimum growth while 
the second term represents the decrease in growth rate, as the temperature goes beyond 
the optimum growth temperature. The maximum specific growth rate obtained from 
isothermal profiles at various temperatures was then fitted into the modified Ratkowsky 
four parameter equations (Eq.2.5) PROC NLIN procedure was used to estimate the 
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parameters of secondary model (SAS program is given in appendix A3.). RMSE and 
pseudo-R
2
 were used to evaluate the performance of the secondary models.  
Dynamic model 
 
Computer simulation algorithm was developed for predicting Salmonella spp. growth 
under dynamic temperature conditions. The secondary model (Eq. 2.5) was incorporated 
into the differential form of the Baranyi model (Eq. 2.1a, 2.1b) and then solved 
numerically using the fourth-order Runge-Kutta method by using the MATLAB 7.0 
package to predict the microbial population at each time step of 5 min (MATLAB 
program is given in Appendix 4) for 5-15 and 10-40
o
C sinusoidal profiles. Root Mean 
Square Error (RMSE) (Eq. 2.4) was used to compare the observed and predicted values 
(Jeyamkondan et al., 2001). 
RESULTS AND DISCUSSION 
 
The types and numbers of the foodborne pathogens present in foods determine the human 
health risk (Rose et al., 1995; Holcomb et al., 1999). Microbial growth in food can be 
characterized by the parameters lag time, growth rate, and death rate at any specific point 
of time. These parameters are affected by the intrinsic factors associated with the food 
product (e.g., pH and water activity), and the extrinsic factors associated with food 
processing, storage and handling (e.g., processing method, temperature, preservatives, 
etc.). Mathematical models that combine microbial growth parameters with 
environmental conditions (Gompertz, 1825; Baranyi et al., 1992) have been important 
tools for predicting microbial growth in contaminated foods.  
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Selective media (XLD) was used to determine Salmonella spp. populations for all 
temperatures and of temperatures >35
o
C, non-selective medium (TSA) was also used to 
estimate injured cells (Fig. 2.6). Salmonella spp. populations differed by < 0.5 log 
CFU/ml between selective and non selective media at 37, 39 and 41
o
C, indicating 
minimal injury. Difference in growth rate of Salmonella spp. in liquid whole egg and egg 
yolk (Gumudavelli et al., 2007) can be found in Fig. 2.7 at different temperatures. It is 
evident that Salmonella grew faster in egg yolk than liquid whole egg which concluded 
that same models can not be used for different food matrix. Growth rate of Salmonella 
spp. in both yolk and liquid whole egg differed maximum at temperatures > 35
o
C. At 
lower temperature 10 and 15
o
C the difference in growth rate of Salmonella spp.in egg 
yolk and liquid whole egg was lesser than the higher temperatures  
Primary Model 
 
Primary models were fitted for Salmonella spp. growth data in liquid whole egg obtained 
at isothermal conditions of 10, 15, 20, 25, 30, 35, 37, 39, 41, and 43°C (Fig 2.2). No 
growth of Salmonella spp. was observed at < 8oC as well as > 45oC in liquid whole egg 
(Fig. 2.1). Gurtler and Conner (2009) reported no growth of SE in whole shell egg at 7°C 
for 8 days, which is in agreement with our results. RMSE and pseudo-R
2 
values 
calculated for fitting Baryani model for each isothermal profile are shown in (Fig. 2.3).  
The h0 values were estimated for growth data of Salmonella spp. at all isothermal 
temperature profiles individually and an average value of h0 (3.51) was fixed and used for 
fitting the Baryani model for all temperatures profiles to estimate rest of the three 
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parameters, yo, ymax, and µmax. Juneja et al. (2007) and Gumudavelli et al. (2007) reported 
h0 values as 1.75 (Salmonella spp.) and 1.34 (SE) for Salmonella growth in fresh chicken 
and egg yolk, respectively. The differences in h0 values could be due to differences in the 
substrate used in the studies. h0 represents the physiological conditions of cells before 
they were used up for the experiment. This indirectly impacts the lag phase and growth 
rate of bacterial cells. We got higher h0 value in comparision to Gumudavelli et al. (2007) 
which clearly demonstrate the difference in growth rate as well as lag phase observation 
of Salmonella cells in different medium. It can be assumed that Salmonella cells 
experienced a longer lag pahse and slower growth rate in whole egg than egg yolk. 
Difference in growth rate can be observed from secondary model fitting (Fig. 2.7) as 
Gumudavelli et al. (2007) used egg yolk to observe the growth parameters of Salmonella 
spp. cells. Amézquita et al. (2005) and Gumudavelli et al. (2007) used a similar approach 
for developing growth model of Clostridium perfringens and SE in cooked boneless ham 
and egg yolk, respectively. Juneja et al. (2007) stated that Baranyi model resulted in 
better estimated growth rate than the modified Gompertz model or the logistic model in 
their study of Salmonella growth in chicken for best fit of secondary model.  
Secondary model 
 
Microbial growth curve includes a lag phase followed by an exponential phase, followed 
by a decreasing growth rate (down to zero), resulting in a maximum number of organisms 
which is stationary phase. A growth model with three parameters can describe bacterial 
growth curve (Zwietering et al., 1990). Ratkowsky et al. (1982) described a square root 
43 
 
model given below which was based on the observations that the square root of specific 
growth rate is linear with temperature at lower temperatures. 
µmax=[b(T-Tmin)]
2……………………………………………………….(2.7) 
Later, Ratkowsky et al. (1983) expanded the previous model to describe the growth rate 
around the optimum and the maximum temperatures. The expanded square root model 
was 
                  µmax = (b(T - Tmin) - {1 - exp[c(T - Tmax)]})
2………………………………(2.8) 
A disadvantage of the expanded form is that it predicts positive values of growth rate 
even for temperatures above Tmax. So, the model does not hold well for temperatures 
above Tmax. Hence, Zwietering et al. (1991) modified the Ratkowsky model and is 
expressed as: 
                 µmax = [b(T - Tmin)]
2
 . {1 - exp[c(T - Tmax)]}…………………………..........(2.9) 
Zwietering et al. (1991) stated that the modified form of Ratkowsky model was most 
suitable for describing the growth rate and the asymptote as a function of temperature.  
The secondary model (Eq. 2.9) fitted to the estimate growth rate of Salmonella spp. in 
liquid whole egg is shown in Fig. 2.4. The theoretical minimum (Tmin) and maximum 
(Tmax) temperatures for Salmonella spp. growth in liquid whole egg were estimated as 
6.10 and 45.19°C, respectively although Salmonella spp. growth was not observed from 
experimental data at 7 and 45°C. The Tmin and Tmax are model parameters which are 
usually 5-10°C below or above the observed minimum and maximum temperatures of 
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growth, respectively (Ross and Dalgaard, 2004). The RMSE and Pseudo-R
2
 values were 
0.06 h
-1
 and 0.99, respectively for the secondary model fitting. Modified Ratkowsky 
model was used by Juneja et al. (2007) for secondary modeling of Salmonella growth rate 
in chicken. Gumudavelli et al. (2007) also used same model and stated its robustness for 
constructing dynamic model. 
 
Dynamic model 
 
Validation of the dynamic model is essential to evaluate the construction and robustness 
of model (Oscar, 2005). Two sinusoidal temperature profiles were selected for validation 
of Salmonella spp. growth model in liquid whole egg. Parameters obtained from primary 
model and secondary model fit were used as inputs for the dynamic model to predict the 
growth. Parameters yo (2.5), ymax (8.7) and h0 (3.51) values from primary model, Tmin 
(6.10), Tmax (45.19), b (0.0016) and c (0.2014) parameter values from secondary model 
were used. Baranyi et al. (1995) developed a dynamic model for predicting the growth of 
B. thermosphacta in broth solutions which predicted well for temperature varying 
conditions. Amezquita et al. (2005) integrated the dynamic model with heat transfer 
model for predicting the growth of C. perfringens in cooked, boneless ham and predicted 
C. perfringens growth curves showed good agreement with validated results. Huang 
(2003) developed simulation algorithm to dynamically estimate and predict the growth of 
C. perfringens in cooked ground beef and the results of computer simulation matched 
closely with the experimental data with the absolute errors of < 0.5 log10 CFU/g. 
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Validation 
 
The observed and predicted values for Salmonella spp. growth in liquid whole egg under 
varying temperatures is shown in Fig. 2.5. The RMSE values for the 5-15°C and 10-40°C 
sinusoidal profiles were 0.28 and 0.23 log10CFU/ml, respectively. Gumudavelli et al. 
(2007) also reported RMSE values < 0.29 log CFU/ml for validation profiles. The 
developed dynamic model predicted growth of Salmonella spp. well in liquid whole egg. 
Gurtler and Conner (2009) reported an increase of 0.4 and 4.5 log CFU/ml in SE 
population at 10°C for 4 days and 23°C for 2 days, respectively in liquid whole egg. 
These increases in Salmonella population are low in comparison to this study. The 
differences may be due to the difference in total solids and/or pH of liquid whole egg 
used in the two studies. Kim et al. (1989) concluded that pH of egg increases during egg 
storage, results in thinning of the albumin which may allow SE to be effective in reaching 
the yolk for accessing the nutrients required for growth and reproduction. Gurtler and 
Conner (2009) observed an increase of 1.5 log CFU/ml in Salmonella spp. counts at 37°C 
for 24 h which is lesser than the increase (6.5 log CFU/ml) observed in present study. 
These differences may be due to different Salmonella spp. serotypes used in the studies. 
Gast and Holt (1995) reported differences in SE growth between (12 strains of SE 
individually inoculated into separate samples of whole egg at a population of 5 CFU/ml, 
increased to levels of between 3.9 and 7.5 log CFU/ml within 24 h at 37
o
C, 
demonstrating the disparity in growth characterstics between serotypes of Salmonella. 
Latimer et al. (2002) reported no increase in SE populations for 720 h days at 10°C while 
the stationary phase was achieved with in 480 h at 10°C in our study. This difference can 
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be due to the use of whole intact shell eggs, while liquid whole egg was used in current 
study. Mixing the yolk and egg white probably lowered the pH of liquid whole egg close 
to pH 7.0 and an increase in the nutrient value of the product.  
Baryani model fitted well for all the isothermal profiles of Salmonella spp. growth in 
liquid whole egg. The maximum growth rate obtained from each primary model was then 
fitted as a function of temperature using the modified Ratkowsky model. The RMSE 
(0.06 h
-1
) and psuedo-R
2
 (0.99) values suggest that the secondary model performed well 
for observed data. Combination of primary and secondary model resulted in a dynamic 
model whose predictions were also validated for two sinusoidal profiles. The dynamic 
model also performed satisfactorily and therefore can be used for predicting growth of 
Salmonella spp. under isothermal as well as temperature varying conditions. 
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                 Figure 2.1. Salmonella spp. growth in liquid whole egg at 47°C 
 
 
 
0.00
2.00
4.00
6.00
8.00
10.00
0 2 6 10 16 24
L
o
g
 C
F
U
/m
l
Time (h)
Rep 1 Rep 2
51 
 
 
 
 
 
 
 
52 
 
 
 
Figure 2.2. Salmonella spp. growth data on XLD from different isothermal profiles 
fitted to the Baranyi model (▲ Rep.1, ■ Rep.2, – predicted).  
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Figure 2.3. RMSE and Pseudo-R
2
 values at each temperature obtained after growth 
data fitted to Baranyi model  
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                                                                           ■ Observed, – predicted 
Figure 2.4. Secondary model describing the growth rate of Salmonella spp. in liquid 
whole egg at different temperatures  
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▲ Rep.1, ■ Rep.2, – temperature, … predicted 
Figure 2.5. Validation of the predictive model at different time-varying  
temperature profiles 
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▲ Rep.1 (XLD), ■ Rep.2 (XLD),      Rep.1 (TSA),     Rep.2 (TSA) 
 
         Figure 2.6. Salmonella spp. growth data on TSA and XLD at higher 
temperatures  
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Figure 2.7. Comparision of growth rate values of Salmonella spp. in different 
medium   
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The one-letter amino acid codes used in text.   
A         Alanine  
C         Cysteine  
D         Aspartic acid  
E         Glutamic acid  
F          Phenylalanine  
G         Glycine  
H         Histidine  
I          Isoleucine  
K         Lysine  
L         Leucine  
M        Methionine  
N         Asparagine  
P          Proline  
Q         Glutamine  
R         Arginine  
S          Serine  
T         Threonine  
V         Valine  
W        Tryptophan  
Y         Tyrosine 
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INTRODUCTION 
 
Egg and egg products have a variety of uses as an ingredient in foods like mayonnaise, 
ice cream, noodles, pet food, etc. Egg white is mainly used for its functional properties. 
In addition to its use for the functional properties, egg whites are being used for 
preparation of hydrolysates for their anti-hypertensive, anti-cancer and anti-adhesive 
properties. The enzymatic hydrolysis products of egg white are being used in the health 
care industry for their angiotensin I- converting enzyme (ACE) inhibitory activity. The 
hydrolysates of egg yolks, egg white, milk, soy sauce, fish and tuna have been found to 
reduce the blood pressure in spontaneously hypertensive rats (SHRs) and hypertensive 
human objects (Miguel et al., 2004). Peptides from egg white and yolk have also been 
shown to have antibacterial activity against certain microorganisms and their antioxidant 
potential (Davalos et al., 2004). Therefore, egg peptides may open up profitable new 
product opportunities for the egg industry. While the egg white hydrolysates can provide 
various health benefits, their manufacturing processes have not been evaluated for 
microbiological safety.  
Traditional egg white hydrolysate manufacturing processes involve hydrolysis of egg 
white with pepsin, trypsin, chymotrypsin and similar enzymes to yield peptides of 
appropriate properties (Miguel et al., 2004). This involves co-incubation of the liquid egg 
white with a particular enzyme or a sequence of enzymes at their temperature and pH 
optima for sufficient time to hydrolyze the proteins. While some enzymes have pH 
optima (pepsin, 2.0) which would prevent the growth of pathogens, other enzymes may 
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have both temperature and pH optima that would allow the growth and potentially 
produce heat stable toxin. Spore forming foodborne pathogens C. perfringens and B. 
cereus that can survive traditional heating processes are of concern. The raw material 
(egg white) solutions are often pasteurized to destroy indigenous flora. These heat 
treatment can heat activate which further results in germination and outgrowth of C. 
perfringens and B. cereus which can further outgrow and produce toxins. 
The objective of this study is to evaluate the potential germination and outgrowth of C. 
perfringens and B. cereus spores during the manufacture of egg white hydrolysates using 
chymotrypsin and trypsin. 
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LITERATURE REVIEW 
Bacterial Spores 
 
Basic Information 
 
Bacterial spores are highly specialized, differentiated cell types which can survive 
adverse environmental conditions. Spores are formed by a number of bacteria to survive 
the unfavorable conditions for growth, but bacterial endospores (spores) are the longest 
surviving organism, being the toughest among all these cell types (Errington, 2003). 
Spores of spore forming organisms are ubiquitous and present challenges to the food 
industry as they can survive several of the food processing unit operations. Spore 
formation involves a unique process of cell division, engulfing the smaller cell, leading to 
the sacrifice of original bacterial cell for producing a single spore. Spores have a dormant 
metabolism (Lewis, 1969) and are highly resistant to adverse conditions, such as 
starvation, high temperatures, ionizing radiation, chemical solvents, detergents, 
hydrolytic enzymes, desiccation, pH extremes and antibiotics (Setlow, 2000). Because of 
their metabolic dormancy, bacterial spores do not require any nutrients or energy source 
to survive (Keynan, 1972). This dormancy and their resistance are the main reasons of 
survival for extreme periods of time. Numerous reports have documented the isolation of 
viable spores from environmental samples such as dried soil in herbarium collections, 
paleosols, ancient lake sediments, permafrost soils, ice cores and old cans of meat. These 
samples ranged in age from several decades to thousands of years (Sussman and 
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Halvorson, 1969b; Gest and Mandelstam, 1987; Potts, 1994; Parkes, 2000; Nicholson, 
2004). 
Spore Structure 
 
The structure of the spore contributes to its unique properties of spores (Tipper and 
Gauthier, 1972; Warth, 1978). The spores consist of a core, surrounded by the inner 
membrane, cortex, outer membrane, coat and in some species, the exosporium. Core, the 
innermost part of spore contains the spore cytoplasm which includes cytoplasmic 
proteins, ribosomes and DNA. The water contents of core cytoplasm and vegetative cell 
cytoplasm is 30-50% and 70-88%, respectively (Potts, 1994; Setlow, 1994; 2000). This 
dehydrated state plays an important role in spore longevity, dormancy and resistance 
(Setlow, 2000). The pH of the cytoplasm is less in spore coat when compared to 
vegetative cell, with a value 6.3-6.5 (Setlow and Setlow, 1980). The core contains large 
quantities of small acid soluble proteins (SASP; Setlow, 1988). These proteins form a 
complex with DNA and force DNA into a special compressed condition (Frenkiel-
Krispin et al. 2004; Douki et al. 2005) and protecting its DNA from damage (reviewed in 
Setlow, 1988; 1995). Core cytoplasm contains large amounts of divalent cations (Ca
2+
)  
which  forms a complex with the spore-specific compounds Pyridine-2,6-dicarboxylic 
acid (dipicolinic acid or DPA; Powell,1953). During germination, DPA and calcium are 
excreted from the core and play important roles in several steps of the germination 
process (Paidhungat et al.. 2001; de Vries, 2004). Most of the lipids in inner membrane 
surrounding the spore coat of dormant spores are immobile, while in germinated spores 
and vegetative cells, the membrane is fluid and the membrane lipids are highly mobile 
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(Cowan et al., 2004). The inner membrane was thought to be the main permeability 
barrier of spores (Setlow, 1994; 2000), and is an important site for spore germination 
receptors (Hudson et al., 2001; Paidhungat et al., 2001). 
Cortex built around the inner membrane is a thick cell wall composed of modified 
peptidoglycan (Warth and Strominger, 1972), is electro-negatively charged (Gould and 
Dring, 1975) and loosely cross-linked (Popham and Setlow, 1993). During germination, 
lytic enzymes in the dormant spore degrade the cortex peptidoglycan. The spore coat is 
an intricate protein structure generally consisting of three distinct layers built around the 
outer membrane (Henriques et al., 2004). The coat protects the cortex peptidoglycan from 
enzymatic attack (Driks, 1999; 2002; Setlow, 2000). The inner layer of the coat contains 
a lytic enzyme, which helps in degradation of cortex during germination (Paidhungat et 
al., 2001; Bagyan and Setlow, 2002; Ragkousi et al., 2003). In many species, the spore 
coat is surrounded by a membrane-like structure called exosporium and contributes to the 
spore hydrophobicity and adherence properties (Koshikawa et al., 1989; Faille et al., 
2002). 
 
Fig 3.1 Internal structure of a bacterial spore (Foster and Johnstone, 1990) 
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Spore Formation 
 
Sporulation is initiated by phosphorylation of the master transcription regulator, Spo0A. 
Together with σH, phosphorylated Spo0A triggers the asymmetric sporulation division, 
septation. Septation produces two distinct cells with very different fates, the smaller pre-
spore (also known as fore-spore), which develops into the spore, and the larger mother 
cell necessary for spore formation but lyses finally. 
The changes in gene regulation are coupled to morphogenesis and to each other by inter-
compartmental signaling, eventually leading to the development of the resistance 
properties that characterize bacterial spores. Subsequent to maturation of the spore of the 
mother cell programmed cell death occurs and the mature spore is released into the 
environment.  
 
Fig. 3.2 Sporulation cycle of Bacillus subtilis (Errington, 2003) 
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Spore Germination 
 
Spore germination involves a series of degradative reactions involving destruction of 
compact spore structure and ultimately leads to loss of spore dormancy and resistance. 
The subsequent steps that lead to cell-division and increase in number through cell 
division is termed as outgrowth, is considered to be a separate process, distinct from 
germination (Campbell and Leon, 1958). Activation step can enhance germination by 
several treatments like heat-treatments, time, and certain chemicals (Keynan and 
Evenchick, 1969; Foster and Johnstone, 1990). Spores comprise of sensors which trigger 
the germination when exposed to favorable condition. Sensors located in inner 
membrane, nutrient receptors or germinant receptors (Hudson et al., 2001; Paidhungat et 
al., 2001). Specific molecules or agents (germinants) recognize a signal of conditions 
suitable for growth. Some of the germinants are amino acids (especially L-alanine), 
sugars and ribosides (Hornstra et al. 2005). Igarashi and Setlow (2005) demonstrated 
interaction between sub-domains from different receptors, supporting the hypothesis of 
interaction between different receptors and formation of complexes (McCann et al. 
1996). Binding of germinant to its receptor triggers transmittance of unidentified signals 
resulting in fast, irreversible changes which ultimately lead to a fully germinated spore. 
Bacillus cereus 
 
B. cereus belongs to the Bacillus cereus group which also includes B. 
weihenstephanensis, B. mycoides, B. pseudomycoides, B. thuringiensis, and B. anthracis 
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(Jensen et. al., 2003). B. cereus can cause systemic and local infections, and severe ocular 
infections (Kotiranta et al., 2000; Callegan et al., 2003; Chan et al., 2003). However, B. 
cereus is known for its ability to cause food-poisoning, and is an important spoilage 
organism in pasteurized dairy products as well. The cells are rod-shaped, straight, 
typically 0.5-2.5 μm in diameter and 1.2-10 μm in length and are mostly arranged in pairs 
or chains (Holt et al., 1994). The cells stain Gram-positive, although positive staining is 
often difficult to obtain in older cultures (Varnam and Evans, 1991). B. cereus cells are 
motile by peritrichous flagella (Varnam and Evans, 1991) and the endospores are 
centrally or pericentrally positioned. B. cereus is a mesophilic, facultatively anaerobic 
bacterium (Griffiths and Schraft, 2002) and is able to grow at redox-potential below -200 
mV (Varnam and Evans, 1991). B. cereus has an essential requirement for three L- amino 
acids: threonine, leucine, valine (Agata et al., 1999) for growth. The temperature range of 
growth is 4-55°C (optimum 30-40 °C) (Roberts et al., 1996). Psychrotrophic strains are 
common and growth may occur at temperatures of 4-5 °C. The minimum water activity 
(aw) for growth is 0.93 and the pH range is 4.3 - 9.3 (Forsythe, 2000). 
B. cereus spores are ubiqutous, and have been isolated from a wide variety of 
environments (Kramer and Gilbert, 1989; Kotiranta et al., 2000; Granum, 2001). B. 
cereus has long been considered to be a soil inhabitant. However, recent genome analysis 
revealed that B. cereus is specialized in protein metabolism indicating a symbiotic or 
parasitic niche rather than a saprophytic life-style as a benign soil bacterium (Ivanova et 
al., 2003). B. cereus is capable of causing anthrax-like symptoms due to the presence of a 
plasmid that is highly similar to one of the characteristic plasmids of B. anthracis 
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(Hoffmaster et al., 2004). Several researches have concluded that the major germinant of 
B. cereus spores is inosine (Yousten, 1975; Hornstra et al., 2007). Glycine and other 
neutral L-amino acids and purine ribosides induce germination (Warren and Gould, 1968; 
Griffiths and Schraft, 2002; Hornstra et al., 2006). L-alanine is the most effective amino 
acid stimulating germination (Yousten, 1975; Griffiths and Schraft, 2002; Hornstra et al. 
2007).  
B. cereus in Foods 
 
The microbial safety of food has been improved significantly over the last few decades. 
B. cereus spores can enter the food chain through raw materials due to their ubiquity. It is 
a major problem in convenience foods and mass catering (Guinebretière et al., 2006). The 
high resistance of the spores allows B. cereus to survive most drying and cooking 
processes and can grow well in cooked food due to lack of a competing microbiota. It is 
practically impossible to completely avoid the presence of B. cereus in raw milk samples 
because B. cereus spores are ubiquitous and are present in the farm environment like soil, 
cattle feed and cattle. B. cereus spores germinate more efficiently in pasteurized milk 
than in raw milk (Wilkinson and Davies, 1974; te Giffel et al., 1995). Hence, germination 
prior to pasteurization is reduced, but enhanced after pasteurization, thus increasing not 
only the chances for survival of the pasteurization resulting in outgrowth and spoilage 
during storage. Langeveld et al. (1996) showed that the probability of disease caused by 
consumption of pasteurized milk containing high numbers of B. cereus is very low. Thus, 
the main issue with B. cereus in dairy products has been spoilage rather than poisoning. 
B. cereus causes two distinct types of food poisoning: the emetic type and the diarrheal 
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(Granum and Lund, 1997; Granum, 1994; 2001; Schoeni and Wong, 2005). The emetic 
syndrome is associated with fried or cooked rice and pasta. While going through events 
leading to outbreaks, it was found that these foods were stored at room temperature after 
preparation which allowed B. cereus to grow rapidly and produce toxin in food. The heat 
stable, circular peptide antibiotic toxin responsible for emetic symptoms is known as 
cereulide, (Agata et al. 1995) is produced by non-ribosomal peptide synthetase (Horwood 
et al. 2004). These potassium ionophore properties exhibited by cereulide can be 
responsible for the disease symptoms caused by B. cereus (Mikkola et al., 1999). The B. 
cereus cereulide is heat stable and cannot be destroyed by normal heating of food. The 
symptoms include nausea, vomiting, malaise and followed by diarrhea (Kramer and 
Gilbert, 1989). Generally, the symptoms are relatively mild and disappear within 24 h, 
however there has been one case of liver failure and death caused by cereulide (Mahler et 
al., 1997). The diarrheal type of food poisoning is caused by enterotoxins, and is mostly 
associated with foods rich in proteins. B. cereus produces several enterotoxins along with 
other toxins and virulence factors, such as phospholipases and haemolysins (Granum and 
Lund, 1997; Schoeni and Wong, 2005). The enterotoxins are not heat-stable, and thought 
to be formed in the digestive tract after ingestion of food containing B. cereus spores 
which later form vegetative cells (Kramer and Gilbert, 1989; Granum, 2001). Symptoms 
like abdominal pain, profuse watery diarrhea, rectal tenesmus, and occasionally nausea 
and vomiting can be seen within 8-16 h after ingestion of contaminated foods (Kramer 
and Gilbert, 1989). In a recent outbreak, three deaths were reported and a new 
enterotoxin, CytK was identified (Lund et al. 2000). Majority of B. cereus foodborne is 
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under response due to the mild symptoms (Kramer and Gilbert, 1989). Risk assessment 
have indicated that B. cereus is a hazard of major importance in various foodstuffs, 
especially cooked chilled foods (Carlin et al., 2000; Nauta et al., 2003). The reported 
foodborne outbreaks and cases attributed to B. cereus in North America, Europe and 
Japan range from 1% to 22% for outbreaks covering 0.7- 33% of the cases (Griffiths and 
Schraft, 2002). 
Clostridium perfringens 
 
The genus Clostridium belongs to Bacillaceae family. Clostridium perfringens is a Gram-
positive, anaerobic, endospore-forming and rod-shaped bacteria (McClane, 2001). C. 
perfringens is an anaerobic organism, but can withstand 5% of oxygen (Futter and 
Richardson, 1971). C. perfringens is ubiquitous in nature including soil, water source and 
the intestinal tract of humans and animals (McClane, 2001). C. perfringens was first 
described in 1892 by Welch and Nuttall known earlier commonly as C. welchii 
(Hatheway, 1990). C. perfringens can grow vigorously between 20°C and 50°C and 
shows hemolysis when grown on blood agar plate (Hatheway, 1990). Based upon their 
ability to produce a variety of toxins, C. perfringens has been categorized into types A-E. 
C. perfringens cells survive stomach passage and sporulate in the intestinal lumen when 
large quantities of cells are ingested with food. During lysis of the mother-cell to release 
the spore, the enterotoxin is released. C. perfringens has been associated with many 
animal diseases including enterotoxemia, myonecrosis, hemorrhagic gastroenteritis and 
many other enteric diseases. According to a survey of foodborne disease outbreaks in the 
United States from 1998-2002, C. perfringens Type A is the third most common cause of 
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foodborne infection (Lynch et al. 2006). In addition to foodborne illness, C. perfringens 
type A are also capable of causing non-foodborne illness such as antibiotic associated 
diarrhea (Sarker et al., 2000). The virulence of C. perfringens is attributed to its ability to 
produce multiple toxins, a short generation time (8 min) and the ability of spores to 
survive environmental stress. 
Clostridium perfringens in foods 
 
C. perfringens type A is a common cause of human gastrointestinal illness in the United 
States and Europe (Bean et al. 1996; Todd, 1997). C. perfringens type A is also 
implicated in non-foodborne animal and human diseases (Borreillo et al., 1985; Brett et 
al., 1992; Jackson et al. 1986; Collie and Mcclane, 1998). It was estimated that 
approximately 5% to 20% of all cases of antibiotic-associated diarrhea (ADD) and non-
foodborne sporadic diarrhea are caused by C. perfringens type A. Symptoms associated 
with C. perfringens type A food poisoning are caused by the C. perfringens enterotoxin 
(CPE) (Sarker et al., 1999). The disease develops with the consumption of food 
contaminated with enterotoxigenic C. perfringens (Rood, 1997). Spores of C. perfringens 
can survive cooking process traditionally used to prepare foods and can grow to large 
populations if held at improper temperatures. When foods containing large numbers of C. 
perfringens are ingested, the majority of the vegetative cells are destroyed by the acidic 
condition of the stomach. However, a small number of the population will survive and 
enter into the intestine. The intestine is an environment that favors C. perfringens to 
multiply and then sporulate. CPE is produced and released into the environment when the 
endospores are fully matured and the mother cell undergoes autolysis (Rood, 1997; Zhao 
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and Melville, 1998). Symptoms of C. perfringens type A food poisoning typically start 
around 12 h after consumption of contaminated foods, with diarrhea and cramps being 
the most commonly reported symptoms. In normal adults, symptoms usually persist for 
12-24 h and then resolve spontaneously (McClane, 2000, Sarker et al., 2000). However, 
in immunocompromised individuals such as the elderly, C. perfringens type A food 
poisoning are the fifth leading cause of death from food poisoning in the United States 
(Brett et al., 1992, Lynch et al., 2006). The disease is diagnosed by the characteristic 
delayed onset of symptoms as well as detection of toxin in the feces of patients (Rood, 
1997). 
 C. perfringens has been isolated from many foods with majority of cases from meat 
products (CDC, 2006). Raw meat like 66% of fresh swine meat, 26% of fresh cattle meat, 
3% of cattle carcasses, 79% of poultry carcasses, 12% of pork organ meat, 39% of 
ground pork meat, and 81% of processed pork products are contaminated with C. 
perfringens (National Research Council, 1999). Processing of meat increases distribution 
of this pathogen: 2% of whole muscle meat samples are contaminated, while after 
emulsification 49% of the samples are infected (Taormina et al., 2003). Other sources of 
C. perfringens are spices; 59% of different spice samples are contaminated (Boer and 
Boot, 1983). Microorganisms encounter many temperature effects during processing of 
cooked food. Subsequently, these foods are cooled and kept below 7°C or are held above 
60°C to inhibit bacterial growth. Spores of C. perfringens, however, survive cooking. 
Subsequent hot holding at temperatures ≥ 60°C does not reduce spore numbers and  
germination will occur when the temperature is not sufficiently high (Strong and Ripp, 
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1967). Foods that are inadequately cooled permit growth of C. perfringens to high cell 
numbers (Juneja et al. 2001; Juneja and Marks, 2002). 
Functional Peptides from Eggs 
 
Short chain peptides derived from different sources such as egg yolk, egg white, 
lysozyme, fish, milk etc. have been shown to possess antimicrobial properties. 
Antimicrobial peptides are small molecular weight segment of proteins which are 
effective against bacteria, viruses, and fungi. Generally, these peptides are positively 
charged and have both hydrophobic and hydrophilic side chains, which make them 
soluble in aqueous environments and also allow them to enter lipid-rich membranes. The 
embryo present in egg is protected by egg white proteins against microbial invasion. Two 
major egg white proteins, lysozyme and ovotransferrin, are reported to possess 
antimicrobial activities (Fitzgerald and Murray, 2006). A 92-amino-acid-long peptide 
(OTAP-92) isolated from ovotransferrin was reported to exhibit antimicrobial activity 
through a membrane damage mechanism (Ibrahim et al., 2000). A peptide 
(IVSDGDGMNAW), isolated from egg lysozyme, showed antimicrobial activity against 
Gram negative bacteria E. Coli K-12 (Mine and Kovacs-Nolan, 2004). An active peptide 
was obtained from an egg white protein after fermentation with Saccharomyces 
cerevisiae (yeast) (Kassaify et al., 2005). Ingestion of this product has been proved to 
increase the non-specific activity of neutrophils. Peptides derived from a tryptic digest of 
egg proteins were shown to trigger the nonspecific immune defense system by 
stimulating superoxide anions (Mine and Kovacs-Nolan, 2004). 
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Bioactive peptides derived from different sources play an important role in the body„s 
regulatory system. Antihypertensive peptides derived from various food proteins are 
major types of this group. Although egg contains more than 40 different proteins, the 
ACE (Angiotensin Converting Enzyme) inhibitory peptides reported were mostly derived 
from ovalbumin (López-Fandiño et al., 2007).  
Hypertension 
 
According to the World Health Organization (WHO) 17.5 million people deaths have 
been attributed to cardiovascular diseases in 2005, 31% of all global mortality (Padwal et 
al., 2009). Hypertension is one of the well-defined risk factors in cardiovascular disease 
and is defined as a condition in which systolic blood pressure is greater than 120 
millimeters of mercury (mm Hg) and/or a diastolic pressure greater than 90 mm Hg. In 
North America, 79.4 million people have some type of cardiovascular disease; of those 
72 million have hypertension (Whelton, 2004). 
The renin-angiotensin system is an important pathways for controlling blood pressure. In 
humans, the main components of the renin-angiotensin system (RAS) are renin, 
angiotensin-converting enzyme (ACE), and angiotensinogen. Renin is synthesized in the 
human kidneys, stored in the afferent arterioles, and released in response to 
hemodynamic, neurogenic, and ionic signals (Hackenthal et al., 1990; Sealey and Laragh, 
1990). Renin is an aspartyl protease that has a very high specificity for angiotensinogen 
(Zhu et al., 2006). Angiotensinogen is a 58 kilodalton (KDa) protein synthesized and 
released from the liver (Nasjletti and Mason, 1972). Angiotensin-converting enzyme 
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(ACE) [EC 3.4.15.1], which is also known as kinase II, is a metallo-protease with two 
zinc active catalytic sites. Renin cleaves angiotensinogen and releases amino terminal 
decapeptide angiotensin I [DRVYIHPFHL] (Ang I). ACE then cleaves Ang I and 
releases two carboxy-terminal amino acids (HL). The resulting octapeptide is called 
angiotensin II (Ang II) (Ng and Vane, 1967). Ang II is a potent vasoconstrictor, whereas 
Ang I is biologically inactive. Ang II directly stimulates vascular smooth muscle 
contraction, which increases systematic vascular resistance and elevates blood pressure. It 
also stimulates secretion of aldosterone from the adrenal cortex. Aldosterone produces 
kaiuresis and increases sodium and water retention in the body. Additionally, ACE also 
hydrolyzes and inactivates bradykinin [RPPGFSPFR], a potent vasodilator (Sealey and 
Laragh, 1990). Therefore, excessive ACE activity leads to high blood pressure or 
congestive heart failure through an increased rate of vasoconstriction. Thus, inhibition of 
ACE is the therapeutic target for antihypertensive drug development (Hackenthal et al., 
1990). The pharmacological ACE-inhibitors (i.e., captopril and enalpril) are widely used 
for the treatment of hypertension. However, these ACE inhibitors are associated with 
adverse effects including dry cough, hyperkalemia, hypotension, renal failure, decrease in 
white blood cells, and angioedema (Silverberg et al., 2002). Pregnant women or patients 
suffering from kidney problems are urged to avoid synthetic ACE inhibitors (Ben-Sira 
and Oliveira, 2007; Pravenec and Petretto, 2008). Therefore, there is an interest in 
searching for non-pharmacological methods of prevention and management of 
hypertension. Bioactive peptides derived from food sources are generally regarded as 
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safer and economical alternative for the prevention and treatment of hypertension 
(Champagne, 2006). 
 
Fig. 3.4 Rennin-angiotensin system 
Antihypertensive Peptides from different sources 
 
Several ACE-inhibitory peptides have been reported in different food sources (e.g., food-
grains, vegetables, fruits, seeds and legumes, milk and dairy products, seafood, meat, and 
egg) showing in vitro ACE-inhibitory activity as well as in vivo antihypertensive effects 
in animals (spontaneously hypertensive rats [SHRs]) (Opie, 1987; Champagne, 2006; 
Iwai and Matsue, 2007; Bakris et al., 2008) or even in human subjects (Williams et al. 
2004). 
Eggs are an excellent source of well-balanced nutrients. Although egg contains more than 
40 different proteins, the ACE-inhibitory peptides from eggs were mostly derived from 
ovalbumin (López-Fandiño et al., 2007). ACE-inhibitory peptides derived from egg 
proteins are listed in Table 3.1. The peptic hydrolysate of ovalbumin could produce 
several ACE-inhibitory peptides. Three potent ACE-inhibitory peptides, FFGRCVSP, 
ERKIKVYL, and FRAHPFL were isolated from ovalbumin with IC50 values of 0.4, 1.2, 
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and 3.2 M respectively (Lopez-Fandino et al. 2007). Ovokinin (FRAHPFL) is one of the 
most intensively studied vasorelaxing peptides from ovalbumin (Fujita et al., 1995a). 
Ovokinin lowered the blood pressure in SHRs significantly when administered orally 
(Fujita et al., 1995b). Another peptide (RAHPFL), lacking the N-terminus Phe (F) residue 
of ovokinin, was isolated from ovalbumin pepsin hydrolysate (Miguel et al., 2004). 
Under in vitro conditions, this peptide showed weaker ACE-inhibitory activity (IC50 = 
6.2 μM) than that of ovokinin (IC50 = 3.2 μM), but exhibited significant antihypertensive 
activity in SHRs (Miguel et al., 2005). This hexapeptide (RADHPF) has also been 
isolated from chymotryptic digestion of ovalbumin; it has been shown to induce nitric 
oxide-dependent vasorelaxation in an isolated mesenteric artery as well as an 
antihypertensive effect in SHRs (Matoba et al., 1999). Another promising peptide, 
YAEERYPIL was identified from pepsin ovalbumin hydrolysate. This peptide showed 
significant antihypertensive activity in SHRs at a dosage rate of 2 mg/kg (Miguel et al., 
2006b; Potter et al., 2009), but was totally degraded after simulated gastrointestinal 
digestion, and its ACE-inhibitory activity decreased; surprisingly, however, one of its 
main fragments, YPI, significantly decreased blood pressure in SHRs at a dosage rate of 
2 mg/kg (Nakaoka et al., 1987). Pepsin also exhibited the highest proteolytic activity 
toward ovalbumin, although there was not a direct relationship between the level of intact 
protein and the resultant ACE inhibition (Fujita et al., 2000). 
ACE-inhibitory peptide (RDHP) was obtained by hydrolyzing rice protein with trypsin 
(Chen et al. 2007). Optimum conditions included pH and temperature of 8.02 and 37
o
C. 
Peptides were also obtained from wheat (IAP) and barley (EVSLNSGYY) with 
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antihypertensive activity (Kajihara et al., 2008). ACE-inhibitory peptides were obtained 
after treating egg white proteins with pepsin, trypsin and chymotrypsin (Miguel et al., 
2004) where pH of egg white solution was adjusted to 7.8 and 8.0 for chymotrypsin and 
trypsin respectively for hydrolysis. ACE-inhibitory and free-radical scavenging 
properties were recognized in peptides derived from soybean protein hydrolysates which 
have been extensively studied (McCue et al., 2005; Farzamirad and Aluko, 2008). ACE 
inhibitor peptides were also prepared by digesting glycinin with either bovine trypsin or 
chymotrypsin at an enzyme-substrate ratio of 2% (w/w) at 37 °C/18 h (Gouda et al., 
2006). A fermented soybean product, known as douchi, contains a potent ACE inhibitor 
(Zhang et al., 2006). IAYKP, IAY, and KP peptides exhibiting ACE-inhibitory activity 
were obtained by adjusting Spinach Rubisco (10mg/mL) pH to 2.0 with 1.0 N HCl and 
then digestion by pepsin (E/S) 1/100) for 5 h at 37 °C (Yang et al., 2003). 
ACE inhibitory peptides could be released by enzymatic hydrolysis (trypsin and 
chymotrypsin) of water-insoluble proteins (actin, myosin, and collagen), from porcine 
skeletal muscle, and from myosin after 18 h of digestion at 37
o
C (Arihara et al., 2001). 
Peptic hydrolysates of regulatory proteins of porcine, such as tropomyosin and troponin, 
also exhibited in vitro ACE-inhibitory activity. A novel ACE-inhibitory peptide, 
PTHILWGD, was isolated by acid extraction from tuna muscle (Kohama et al., 1988). 
Previous research demonstrated that in vitro incubation of milk proteins with 
gastrointestinal proteases (pepsin, trypsin, and chymotrypsin) resulted in the release of 
ACE inhibitory peptides (Yamamoto and Takano, 1999). Milk fermented by 
Enterococcus faecalis can also produce some ACE-inhibitory peptides (LHLPLP, 
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LVYPFPGPIPNSLPQNIPP, VLGPVRGPFP, and VRGPFPIIV) (Miguel et al., 2006a). 
Two ACE-inhibitory peptides (LQP and MAP) were isolated from enzyme-modified 
cheese (Tonouchi et al., 2008). The Danish skim milk cheese was added with starter 
culture for 16 h/37
o
C followed by treatment with protease N Amano 48 h at 35
o
C. 
Table 3.1 Examples of ACE-inhibitors peptides derived from eggs 
Protein Sequence IC50 (µM) 
Ovalbumin LW 6.8 
 FRADHPFL 3.2 
 RADHPFL 6.2 
 FFGRCVSP 0.4 
 FGRCVSP 6.2 
 ERKIKVYL 1.2 
 YAEERYPIL 4.7 
Ovotransferrin KVREGT 9.1 
 
Safety of egg white hydrolysates Manufacturing Process 
 
Microorganisms are associated with raw agricultural products such as harvested plants, 
slaughtered animals and raw materials in food industry. In 1989, FDA considered the 
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responsibility of food manufacturer for the application of aseptic processing. Among 
these, the requirement of biological validation of the heat treatment applied to the product 
has proved to be the most difficult (Dignan et al. 1989). While foodborne pathogens 
belonging to the genus Bacillus and Clostridium have been isolated from eggs, foodborne 
illness outbreaks from egg products have not been reported. Majority of the thermal 
processes employed in the food industry are designed to destroy vegetative forms of 
foodborne pathogens. In some cases the heat treatments serve to activate spores. Thus it 
is important to predict the ability of spores to survive a heat treatment and also the effect 
of environmental conditions on their subsequent growth. Interactions of environmental 
factors affecting bacterial growth and survival can be safely studied by conducting a 
microbial challenge studies (Rose, 1987). The aim of MCT is to simulate the fate of 
relevant organisms during processing. Therefore, the MCT procedure is generally 
regarded as a means to make sure that a potentially hazardous organism will not survive 
the process (Notermans and in‟t Veld, 1994). There are some important factors to be 
considered while performing microbial challenge testing (Vestergaard, 2001) which 
include 1) microorganism selection 2) inoculation level 3) inoculation method 4) length 
of study 5) product composition and storage 6) microbiological analysis. 
The ideal organisms for challenge testing are those that have been previously isolated 
from similar formulations. Additionally, pathogens from known foodborne outbreaks 
should be included to ensure the formulation is robust enough to inhibit those organisms 
as well. Multiple specific strains of the target pathogens should be included in the 
challenge study (FDA, 2009). It is common to challenge a food formulation with a 
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"cocktail" or mixture of multiple strains in order to take into account potential strain 
variation (FDA, 2009). It is also important to incubate and prepare the challenge 
suspension under standardized conditions and format. Shifts in the incubation 
temperature used to propagate the challenge organisms and the storage temperature of the 
product have been shown to change the length of the lag period of organisms used in the 
challenge study (Curiale, 1991). In certain applications, surrogate microorganisms may 
be used in challenge studies in place of specific pathogens (FDA, 2009). For example, it 
usually is not possible to introduce pathogens into a processing facility; therefore, it is 
desirable to use surrogate microorganisms in those cases. An ideal surrogate is a strain of 
the target pathogen that retains all other characteristics except its virulence (FDA, 2009). 
The inoculum level used in the microbiological challenge study depends on whether the 
objective of the study is to determine product stability and shelf life or to validate a step 
in the process designed to reduce microbial numbers. Typically, an inoculum level of 
between 10
2
 - 10
3
 cells/g of product is used to ascertain the microbiological stability of a 
formulation (FDA, 2009). Higher inoculum levels may be appropriate for other products. 
Depending on the product formulation, some of the inoculum may die off initially before 
adapting to the environment. If too low of an inoculum level is used, the incorrect 
assumption could be made that the product is stable when it is not. Conversely, if the 
inoculum level is too high for this purpose, the preservation system or hurdles to growth 
may be overwhelmed by the inappropriate inoculum size, leading to the incorrect 
conclusion that the formulation is not stable.  
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The preparation of the inoculum to be used in microbiological challenge testing is an 
important component of the overall protocol. Typically, for vegetative cells, 18 - 24 h 
cultures revived from refrigerated broth cultures or slants or from cultures frozen in 
glycerol are used (FDA, 2009). The challenge cultures should be grown in media and 
under conditions suitable for optimal growth of the specific challenge culture. Bacterial 
spore suspensions may be stored in water under refrigeration or frozen in glycerol. Spore 
suspensions should be diluted in sterile water and heat-shocked immediately prior to 
inoculation (FDA, 2009). Quantitative counts on the challenge suspensions may be 
conducted to aid in calculating the dilutions necessary to achieve the target inoculum in 
the challenge product. Correct procedures should be used when carrying out challenge 
tests with certain pathogens. The method of inoculation is another extremely important 
consideration when conducting a microbiological challenge study. Every effort must be 
made not to change the critical parameters of the product formulation undergoing 
challenge.  
It is prudent to conduct the microbiological challenge study up to the desired shelf life of 
product (FDA, 2009). It is also desirable to test the product over and significantly beyond 
its entire shelf life because sub lethal injury may occur in some products. This can lead to 
a long lag period, where it may not be possible to culture the inoculum, but over time, a 
small number of the injured cells can recover and grow in the product.  
Several intrinsic factors like pH, water activity and extrinsic factors like temperature can 
effect significantly on microorganisms growth. It is important to control and note down 
the conditions under which studies are done. Test samples should be stored in same 
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conditions as intended for product storage to obtain accurate results. The selection of 
enumeration media and method depends on the type of pathogens or surrogates used in 
the study. It is highly recommended to check the background flora present in raw 
materials used for preparation of the product. Sometimes, this background flora can 
hinder the growth of organism of our interest and give false result. 
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ABSTRACT 
 
Spore forming foodborne pathogens of the genus Bacillus and Clostridium are a great 
concern in food industry due to ability of the spores to survive normal heat treatments 
used in food manufacturing. The germination and outgrowth of B. cereus and C. 
perfringens spores during the egg white hydrolysates (EWH) manufacturing process was 
evaluated. Egg white solution (2.5%) was inoculated with heat activated B. cereus and C. 
perfringens separately to provide a spore population of ca. 2.0 – 3.0 log spores/ml. EWH 
was prepared by enzymatic hydrolysis of the inoculated egg white solution and 
maintained at optimum pH of enzymes (trypsin and chymotrypsin) for 24 h at 37
o
C. B. 
cereus and C. perfringens populations were enumerated before and after heat shock, at 0, 
4, 8, 12, 18 and 24 h of hydrolysis by plating on corresponding selective medium. SDS-
PAGE was performed on EWH obtained during egg white hydrolysis (non-inoculated 
egg white) with trypsin and chymotrypsin. B. cereus population was increased by > 3.5 
log CFU/ml during the EWH preparation using chymotrypsin, while minimal increase 
was observed during trypsin hydrolysis. No increase in C. perfringens population was 
observed irrespective of the enzyme used. Hydrolysis of major egg proteins by 
chymotrypsin was completed within 4 h of incubation, while minimal hydrolysis of egg 
white proteins was observed with trypsin subsequent to 24 h incubation. Those enzymes 
which doesnot have optimal conditions for the growth of pathogens should be used for 
the manufacturing of egg white hydrolysates. 
Keywords: Bacillus, Clostridium, egg hydrolysates, spore 
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INTRODUCTION 
 
Eggs are used in preparation of several food products like mixes, bakery foods, noodles, 
mayonnaise, salad dressings, candies, ice cream, pet foods, etc. (Kovacs-Nolan et al., 
2005). Egg white and egg white solids have been used primarily for their functional 
properties in the food industry. In addition, egg whites are increasingly being used for 
their health benefits such as antimicrobial, anti-adhesive, immuno-modulating, anti-
cancer, angiotensin converting enzyme (ACE) inhibitor, protease inhibitor and anti-
hypertensive properties (Kovacs-Nolan, 2005). 
Heart disease is a major cause of mortality and remains a major health concern in North 
America (Lo et al., 2005). Hypertension (blood pressure greater than 140 mm Hg systolic 
and/or 90 mm Hg diastolic pressure) is a major risk factor for heart disease (Izzo et al., 
2003; Kannel et al., 2003). Hypertension and cardiovascular diseases afflicts 28.7, 22.0 
and 44.2 % of the population in USA, Canada and Europe, respectively (Kearney et al., 
2004). Rennin-angiotensin system is a hormone system which regulates blood pressure 
and water balance in human body. ACE (dipeptidyl carboxypeptidase, EC 3.4.15.1) is a 
zinc metallopeptidase that plays a central role in regulating blood pressure through the 
rennin-angiotensin system (Laragh et al., 1972). ACE converts angiotensin I to 
angiotensin II, a potent vasoconstrictor and inactivates bradykinin, a potent vasodilator. 
Thus, inhibition of ACE may lead to a reduction in blood pressure and ACE inhibitory 
drugs are commonly prescribed for treating hypertension (Gravas and Gravas, 1999).  
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Food protein-derived angiotensin converting enzyme (ACE) inhibitory peptides are being 
evaluated for reducing hypertension and some are being produced commercially (Hata et 
al., 1996). Although synthetic antihypertensive drugs for inhibiting ACE have been 
successful in lowering hypertension, they exhibit adverse side effects such as cough and 
angioedema (Beltrami and Zimgale, 2006). Therefore, ACE inhibitory peptides from 
food proteins are being evaluated as an alternative for prevention and treatment of 
hypertension (Fitzgerald et al., 2004; Miguel and López-Fandiño, 2005).  
Enzymatic hydrolysis products of egg white are being used in the health care industry for 
their ACE inhibitory activity. The hydrolysates of egg yolks, egg white, milk proteins, 
soy sauce, fish sauce and tuna have been shown to lower blood pressure in spontaneously 
hypertensive rats (SHRs) and hypertensive human subjects (Miguel et al., 2004). Peptic 
and chymotryptic digest of ovalbumin resulted in an octapeptide ovokinin (FRAHPFL) 
and a hexapeptide (2-7 fragment of ovokinin), respectively (Miguel and Aleixandre, 
2006; Fujita et al., 1995) with ACE inhibitory activity. Additional peptides derived from 
egg with ACE inhibitory activity include ESIINF, YRGGLEPINF, YAEERYPIL (Miguel 
et al., 2007a, Miguel et al., 2007b), and LVREGT (Lee et al., 2006). While these egg 
white hydrolysates provide health benefits, their manufacturing processes have not been 
evaluated for microbiological safety.  
Traditional EWH manufacturing processes involve sequential hydrolysis of egg white 
with pepsin, trypsin, chymotrypsin and/or similar proteases to yield peptides with specific 
properties (Miguel et al., 2004). This involves co-incubation of liquid egg white with 
appropriate enzyme at its optimum temperature and pH for sufficient length of time to 
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hydrolyze the egg white proteins. While some enzymes have the pH optima at low pH 
values (pepsin, pH optima ca. 2.0) that would prevent growth of foodborne pathogens, 
other enzymes may have both the temperature and pH optima that would allow growth of 
microorganisms. This may result in growth of foodborne pathogens present in raw 
materials to hazardous levels and potentially produce toxins. Thus, it is necessary that 
microbiological safety of these processes is evaluated to assure safety of the final 
products. The organisms of concern during EWH manufacturing include the spore 
forming pathogens C. perfringens and B. cereus, the spores of which can survive 
traditional heating processes and can grow and produce toxins. Salmonella spp. has a 
high prevalence in eggs and poultry facility than mentioned spore formers but worst it 
would be worthwhile to evaluate the process for organisms like spore formers which are 
difficult to kill and avoid due to their heat resistance and ability to survive thermal 
treatment usually involed in egg white hydrolysates manufacturing process. Spores of 
Bacillus and Clostridium spp. have been isolated from eggs and poultry facilities 
(Siragusa et al., 2004; Siragusa et al., 2006; Ansah et al., 2009). The objective of this 
study was to evaluate the potential germination and outgrowth of C. perfringens and B. 
cereus spores during the manufacture of egg white hydrolysates. 
MATERIALS AND METHODS 
Microorganisms 
 
Three different enterotoxin-producing strains of C. perfringens, NCTC 8238 (Hobbs 
serotype 2), NCTC 8239 (Hobbs serotype 3) and NCTC 10240 (Hobbs serotype 13) and 
seven strains of Bacillus spp. producing emetic or diarrheal toxins (B. cereus ATCC 
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14579, FERN 1, FERN 40, 7401, 665; Bacillus spp. FERN 110; B. thuringiensis FERN 
7) were used in the study. 
Preparation of spores 
 
Spores of C. perfringens strains were prepared following the procedure outlined by 
Juneja et al. (1993). Briefly, an aliquot (0.1 ml) from the stock culture was inoculated 
into 10 ml of freshly prepared fluid thioglycollate medium (FTM; Becton Dickinson and 
Company, Cockeysville, Md). The spores were heat activated for 20 min at 75°C in 
circulated water bath (Isotemp 3013H, Fisher Scientific, Fair Lawn, Nj) and then cooled 
in an ice chilled water followed by the incubation for 18 h at 37°C. A 1.0 ml portion from 
this culture was transferred to 10 ml of freshly steamed FTM and then incubated for 4 h 
at 37°C. The fresh culture (1%) was transferred to modified Duncan Strong (DS) medium 
and incubated aerobically for 24 h at 37°C. The original DS formulation was modified by 
replacing starch with 0.4% raffinose (Sigma Chemical Co., St. Louis, Mo) and 
supplemented with 100 mg/L of caffeine (Sigma Chemical Co., St. Louis, Mo) to 
improve sporulation. Spores of each strain were harvested by centrifugation at 7,012 x g 
for 20 min at 4°C (CS-15R, Beckman, Palo Alto, Ca) and washed twice with 50 ml of 
sterile distilled water. The spore crop of each strain was re-suspended in 10 ml sterile 
deionized water and stored separately at 4°C until use. A spore cocktail containing all 
three strains of C. perfringens spores was prepared immediately before experiments by 
mixing approximately equivalent numbers of spores from each strain suspension.  
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Spores of Bacillus spp. strains were prepared following the procedure outlined by 
Beuchat et al. (1997). Briefly, stock cultures were activated in BHI broth (Becton 
Dickinson and Company, Cockeysville, Md) and incubated at 30°C. Three successive 
loop transfers at 24 h intervals were made before spreading 0.1 ml aliquots of each strain 
onto the sporulation medium (Nutrient agar Becton Dickinson and Company, 
Cockeysville, Md) supplemented with 0.05 g of MnSO4/L). The plates were incubated for 
72 h at 30°C and the spores were harvested by depositing 5 ml of sterile distilled water on 
the surface of each plate and rubbing gently with a sterile bent glass rod. The suspension 
of spores and vegetative cells was filtered through sterile glass wool and collected in a 
sterile tube The washing and filtering procedures were repeated twice. Pooled 
suspensions were centrifuged at 2,600 x g for 20 min at 5°C (CS-15R, Beckman, Palo 
Alto, Ca) and the supernatant liquid was discarded. The resulting pellet was suspended in 
100 ml of sterile distilled water and centrifuged at 6,000 x g for 10 min at 5°C. This 
procedure was repeated twice and the final pellet was suspended in sterile de-ionized 
water and stored at 4°C for use in subsequent experiments. Spore cocktail containing all 
seven strains of Bacillus spp.  spores was prepared immediately before experiments by 
mixing approximately equivalent numbers of spores from each spore suspension. 
Bacterial enumeration 
 
For enumeration of spore population, samples were heated for 20 min at 75°C or for 5 
min at 80°C for C. perfringens and B. cereus, respectively. Ten-fold serial dilutions of 
samples were prepared in sterile 0.1% peptone water (PW; BD Difco, Sparks, MD) and 
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appropriate dilutions were spread or spiral-plated on Tryptose-Sulfite-Cycloserine agar 
(TSC; Oxoid, Basingstoke, UK) without egg-yolk and Mannitol-Egg Yolk-Polymyxin 
(MYP) Agar (Becton -Dickinson and Company, Sparks, Md) used for enumeration of C. 
perfringens and B. cereus, respectively. TSC plates were overlaid with a layer of (8-10 
ml) TSC agar and incubated for 24 h at 35°C in an anaerobic chamber (Bactron IV, 
Sheldon Manufacturing Co., Or) where as MYP plates were incubated aerobically for 24 
h at 35°C. Typical C. perfringens and B. cereus colonies were enumerated and counts 
were expressed as log CFU/ml. 
Preparation of Egg White Solution 
 
Freshly laid eggs were obtained from the University of Nebraska – Lincoln poultry farm. 
Eggs were washed with warm water to remove visible dirt and other particulate material 
from the shells. The washed eggs were subsequently sanitized by dipping in 70% ethanol 
for 15 minutes and dried in a biosafety cabinet (Belco Glass Inc. Vineland, Nj). The 
sanitized eggs were broken with an ethanol flamed knife and the egg white was collected 
in a sterile container. A 2.5% (wt/wt) solution of Egg white was prepared using Milli-Q 
water. The pH of the egg white solution was adjusted to 8.0 and 7.8 with 1 M HCl for 
hydrolysis with trypsin and chymotrypsin, respectively. The egg white solutions for each 
enzyme hydrolysis were equally divided into three portions (ca. 100 ml each) and used 
for following: (i) Clostridium inoculation (ii) Bacillus inoculation (iii) pH monitoring and 
SDS-PAGE (non-inoculated). 
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Measurement of pH 
 
The pH of egg white solution was measured at 0, 4, 8, 12, 18 and 24 h intervals during 
hydrolysis using non-inoculated samples by directly immersing the electrode of pH meter 
(Model Accumet-Basic/AB15, Fisher Scientific, Pittsburgh, Pa) in the sample.  
Egg White Inoculation 
 
The heat activated spores of C. perfringens (75°C/20 min) and Bacillus spp. (80°C/5 min) 
were added to the egg white solution to obtain a final spore concentration of ca. 2.0 - 3.0 
log CFU/ml, respectively. 
Enzymatic Hydrolysis 
 
Trypsin (EC 3.4.21.4 type I, 10,900 U/mg) and chymotrypsin (EC 3.4.21.1 type I-S, 44 
U/mg from bovine pancreas) were purchased from Sigma Chemical Co. (St. Louis, Mo). 
Trypsin and chymotrypsin were added to the inoculated egg white to obtain a 
substrate/enzyme ratio of 1/100 and 5/100 (wt/wt), respectively. The hydrolysis was 
carried out in water bath set and maintained for 24 h at 37°C.  
Sample Collection 
 
Samples were collected at regular intervals (0, 4, 8, 12, 18 and 24 h) from egg white 
during hydrolysis and analyzed for total and spore populations of C. perfringens or B. 
cereus populations. At the end of 24 h incubation period, the enzymes were inactivated 
by placing the samples in a boiling water bath for 15 min. Samples were obtained at 0, 4, 
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8, 12, 18 and 24 h from non-inoculated egg white solution during chymotrypsin 
hydrolysis and heated at 100
o
C for 15 min for inactivation of enzyme and stored at -20
o
C. 
During trypsin hydrolysis, Samples were taken at 0, 4, 8, 12 and 24 h from non-
inoculated batch 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
  
Appropriate dilutions of egg white solution and enzymes (trypsin and chymotrypsin) and 
non-diluted egg white hydrolysates (protein digest) collected at different times during 
hydrolysis were used for SDS-PAGE experiment. All samples were added to Laemmli 
sample buffer (Bio-Rad Laboratories, Hercules, Ca) with 5% β-mercaptoethanol (Sigma-
Aldrich) in equal proportions (50%; wt/wt). The samples and molecular weight standard 
were boiled for 5 min followed by cooling to room temperature. Three molecular weight 
standards (markers) were used: (i) Broad-range protein standard (Biorad Precision Plus 
Standards) containing pure recombinant proteins of the following molecular weights 
(MW), 250, 150, 100, 75, 50, 37, 25, 20, 15, and 10 kDa, (ii) SDS-PAGE broad range 
(Biorad natural standards) protein unstained standards of 200, 116.3, 97.4, 66.2, 45. 31, 
21.5, 14.4 and 6.5 kDa and (iii) SDS-PAGE polypeptide (Biorad natural standards) 
protein unstained standards of 26.6, 17.0, 14.4, 6.5, 3.5 and 1.4 kDa for comparative 
purposes. Aliquots (10 and 40 µl) of each sample were loaded onto each well of 16.5% 
and 10-20 % precast gels (Bio-Rad Laboratories, Hercules, Ca), respectively. 
Electrophoresis was carried out at 200 V, for approximately 30 min and 60 min in 16.5% 
and 10-20 % precast gels, respectively, using Tris-Tricine-SDS running buffer (Biorad 
Laboratories Hercules, Ca). Gels were fixed in a solution of 40% (v/v) methanol and 10% 
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(v/v) acetic acid, stained with 0.025% (w/v) Coomassie Blue R-250 in 10% acetic acid, 
destained in 10% (v/v) acetic acid and finally washed with deionized water. The 
molecular weight and band intensities were recorded in Kodak Image Station 440 CF 
(Kodak, New Haven, Ct).  
RESULTS AND DISCUSSION 
 
The SDS-PAGE patterns of hydrolysates obtained at 0, 4, 8, 12, 18 and 24 h of egg white 
hydrolysis with chymotrypsin and trypsin on 16.5 % and 10-20 % gel are shown in Figs. 
1-4, respectively. Similar types of bands were observed for all samples irrespective of the 
gel concentration. The egg white protein samples produced clear bands near 76, 46 and 
14 kDa compared with molecular weight standards (Figs. 1-3). These bands may 
represent ovotransferrin (76 kDa), ovoalbumin (46 kDa) and lysozyme (14.3 kDa) 
(Miguel and Aleixandre, 2006; Galyean and Laney, 1980). Protein bands near 25, 15 and 
less than 15 kDa were observed for chymotrypsin and trypsin (Figs. 1-4). Chymotrypsin 
and trypsin have a molecular weight of 25 kDa (Burell, 1993) and 24 kDa (Cunningham 
et al., 1954; Walsh et al., 1970), respectively. Bands lower than the molecular weight of 
the enzymes (trypsin and chymotrypsin) could be due to impurities or partial degradation 
of the enzymes. 
Hydrolysates obtained from tryptic digest of egg white solution did not show any change 
in the band patterns at 0, 4, 8, 12 and 24 h of hydrolysis. The inability of trypsin to 
hydrolyse egg white proteins may be due to the presence of ovomucoid which inhibits the 
activity of bovine and porcine trypsin (Liu et al., 1971; Zahenley, 1980). Hydrolysates 
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obtained during hydrolysis of egg white with chymotrypsin at 0 h showed no significant 
change in bands of egg white proteins at 46 and 14 kDa while 76 kDa band 
(ovotransferrin) observed in digested egg white sample. This protein may have produced 
smaller peptides (< 6.5 kDa) which cannot be visualized properly using SDS-PAGE 
analysis. This particular protein band completely disappeared after 4 h of hydrolysis with 
chymotrypsin. Yoshino et al. (2004) reported that pepsin digestion of raw egg white 
proteins of 76.6 kDa mol wt. was rapidly digested within 30 min of hydrolysis. The 14 
kDa band (lysozyme) was completely digested (Figs. 1 and 2) at 0 h during chymotrypsin 
hydrolysis of egg white. All samples were heated for 15 min at 100
o
C for inactivating 
enzyme before storing them for SDS-PAGE experiment. It is possible that the 2 to 3 min 
for samples heating (come up time) may have been enough for the enzyme to digest 
certain protein as in the case of 14 and 76 kDa protein bands during egg white hydrolysis 
with chymotrypsin. Proctor and Cunningham (1988) reported that some proteolytic 
enzymes such as trypsin, chymotrypsin, and papain do not hydrolyze lysozyme, unlike 
pepsin. However, these enzymes hydrolyze denatured lysozyme. The protein band near 
46 kDa (ovoalbumin) is not prominent at 4 h hydrolysate sample compared with time 0 h 
of hydrolysis and was observed throughout the hydrolysis period. Information about 
bands < 6.5 kDa could not be obtained due to absence of lower molecular weight 
markers, also the staining of proteins did not enable lower molecular weight peptides and 
markers to be clearly visualized. Cheng et al. (2008) reported that some low molecular 
weight fragments (< 6.5 kDa) cannot be visualized during chicken leg bone hydrolysis 
with trypsin. Mahmoud (1994) suggested that these partially hydrolyzed proteins were 
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more difficult to define because they encompass a wide range of products with varying 
degrees of hydrolysis and Coomassie Blue staining of proteins did not enable lower 
molecular peptides to be visualized. Majority of the egg white hydrolysis by 
chymotrypsin was completed within 4 h of hydrolysis. Cheng et al. (2008) and Guerard et 
al. (2002) also observed faster emzymatic digestion of proteins during hydrolysate 
prepration initially followed by a slower hydrolysis for chicken leg bone and tuna waste 
hydrolysates, respectively. 
The pH of egg white solutions during trypsin and chymotrypsin hydrolysis are shown in 
Fig. 5. During chymotrypsin hydrolysis of egg white solution, pH of the solution 
decreased from 7.8 to 6.5 within the first 4 h indicating hydrolysis. The pH reduction 
could be due to the peptide residues released during proteolysis (Cheng et al., 2008). The 
pH drop was minimal subsequent to 4 h, and pH 6.2 was observed at the end of 24 h 
incubation. Similar decrease in pH for initial 2 h of hydrolysis was observed by Cheng et 
al. (2008) during hydrolysis of chicken leg bone protein with alcalase and trypsin, 
resulting in an ultimate pH of 6.7-6.9 (from 8.0 after) 12 h of hydrolysis. In contrast, 
changes in pH values of trypsin hydrolysis of egg white solution were not observed 
throughout the incubation period. This may be due to absence of egg white proteins 
hydrolysates as evident from SDS-PAGE results. 
C. perfringens spores did not germinate and outgrow in egg white solution during EWH 
preparation using either of the enzymes (trypsin and chymotrypsin; Figs. 6 and 7). C. 
perfringens populations (before heat shock) decreased during EWH preparation using 
trypsin and chymotrypsin by 0.84 and 1.05 log CFU/ml, respectively. Also, C. 
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perfringens populations (after heat shock) decreased by 0.27 log and 0.13 CFU/ml, 
respectively for the same. Survivors of C. perfringens were recovered from the samples 
after enzyme activation step in hydrolysis carried out with chymotrypsin after 24 h. It 
may be due to the presence of some hydrolysates or breakdown of complex proteins 
present in egg white by chymotrypsin as observed from SDS-PAGE pattern. The inability 
of C. perfringens to germinate and outgrow during egg white hydrolysis with trypsin 
could be explained due to the presence of various antimicrobial factors in the egg white 
which act as antimicrobial like lysozyme. Egg white proteins were present in their native 
state due to inhibition of trypsin activity during hydrolysate preparation process. 
Lysozyme is a 14.6 kDa single peptide that can cause microbial cell lysis by cleavage of 
β (1–4) glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine in 
the peptidoglycan layer of the bacterial cell wall (Proctor and Cunningham, 1988). 
Lysozyme has been successfully used in the cheese industry as a bio-protectant for more 
than 20 years to control Clostridium tyrobutyricum that causes the „late blowing‟ of hard 
and semi-hard cheeses as a result of butyric fermentation (Carini et al., 1985). Literature 
on the inhibitory effect of lysozyme against C. perfringens is limited (Osa et al., 1990), 
although the ability of lysozyme to inhibit several other Clostridium species including C. 
tyrobutyricum, C. thermosaccharolyticum and C. botulinum has been well documented 
(Carini et al., 1985; Hughey and Johnson, 1987). Zhang et al. (2006) showed that 
lysozyme can inhibit C. perfringens growth and destroy the vegetative cells. Iron binding 
protein (ovotransferrin) present in egg white can be another reason for the ability of C. 
perfringens to grow during trypsin hydrolysis of egg white. Even though egg white 
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hydrolysis with chymotrypsin resulted in degradation of ovotransferrin and lysozyme into 
smaller peptides, C. perfringens spore germination and outgrowth was not observed. It 
can be due to antimicrobial activity of smaller peptides obtained due to the hydrolysis of 
lysozyme (Mine et al., 2004).  
In contrast, B. cereus populations (before heat shock) increased in both types of egg 
white hydrolysates preparation using trypsin or chymotrypsin by 0.27 and 3.72 log 
CFU/ml, respectively (Figs. 8 and 9). Also, B. cereus counts (after heat shock) increased 
by 0.15 and 1.18 log CFU/ml, respectively for the same. B. cereus survived the enzyme 
inactivation step subsequent to enzymatic hydrolysis carried out with chymotrypsin. 
Spores of B. cereus are resistant to egg-white lysozyme and can grow in presence of 
lysozyme (Buchanan and Gibbons, 1974). Hughes (1971) demonstrated the resistance of 
B. cereus cell walls to lysozyme at concentrations as high as 100µg/ml. This resistance is 
specifically due to the deacetylation of N-acetylglucosamine residues of the wall 
peptidoglycan (Araki et al., 1972; Hayashi et al., 1973) and is responsible for resistance 
of B. subtilis and B. megaterium to lysozyme (Hayashi et al., 1973). Greater increase in 
B. cereus population was observed during hydrolysis with chymotrypsin compared to 
trypsin. The differences in B. cereus growth can be attributed to degree of hydrolysis or 
break down of egg white proteins into small proteins and the resulting pH reductions. 
Chymotrypsin hydrolysis of egg white resulted in a pH decrease from 7.8 to 6.5 
conducive to the growth of B. cereus optimum pH for growth is from 6 to 7. However, 
similar reduction in pH was not observed during trypsin hydrolysis, probably due to the 
minimal hydrolysis observed with trypsin. 
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The difference in growth of C. perfringens and B. cereus could be due to aerobic 
conditions followed during hydrolysis. C. perfringens grows well under anerobic 
conditions, while aerobic conditions favor B. cereus growth. Ovotransferrin, a 
biologically active protein of egg white is important in the inhibition of microbes (Board 
and Hornsey, 1979) as it deprives microorganisms of Fe
3+
, a property that is accentuated 
by an alkaline nature (pH 9-10) of avian egg whites (Sharp and Whitaker 1927). Tranter 
and Board (1981) reported that chelation of Fe
3+
 by ovotransferrin in the egg white 
influenced swelling of germinating Bacillus spores and prevented the outgrowth to 
normal vegetative cells. An increase in both length and breadth of the spores was 
observed in egg white, as the germinating spore entered the second phase of swelling, 
resulting in a „balloon like‟ form. Finally, the germination of the spore continued, 
although outgrowth was inhibited.  
Iron in the ferrous form (Fe
2+
) present in most of the biological fluids (near pH 7 ) is 
oxidized to ferric (Fe
3+
)
 
in equilibrium with atmospheric oxygen and later will be 
hydrolysed to form polynuclear complexes of extremely low solubility (Spiro and 
Saltman, 1969). Such iron is not available for microorganisms unless they are able to 
solubilize iron from these polymers by the formation of powerful chelates, known as 
siderophores (Snow, 1970; Neilands, 1972; Lankford, 1973). In most cases, these 
chelates are excreted into the medium where they solubilize iron before incorporation 
into the cell through specific transport systems (Cox et al., 1970; Langman et al., 1972; 
Kadner and Bassford, 1978). In an iron deficient environment like egg white due to the 
presence of transferrin, microorganisms have to compete with ovotransferrin for iron, an 
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element essential for microbial growth. Microbial iron-transport compounds play an 
important role in reversing the bacteriostatic action of ovotransferrin. Tranter and Board 
(1981) stated that the three main stages in the conversion of B. cereus spore to vegetative 
cell are germination, swelling and outgrowth. Only the last two stages are affected by hen 
egg white (Hitchins et al., 1963). Saturation of ovotransferrin with iron relieves the 
inhibition of bacterial growth in egg white (Garibaldi, 1960; Board, 1964). The high pH 
of the egg white and its iron-deficient state are responsible for inhibition of B. cereus 
outgrowth during egg white hydrolysate preparation using trypsin. 
In conclusion C. perfringens did not germinate during egg white hydrolysis with either 
trypsin or chymotrypsin. B. cereus was able to germinate and outgrow during egg white 
hydrolysate preparation with chymotrypsin, but lower growth was observed during 
trypsin initiated egg white hydrolysis. Trypsin was unable to hydrolyze egg white 
proteins while chymotrypsin hydrolysed most of the egg white proteins within 4 h. 
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Figure 4.1. Changes in SDS-PAGE pattern of egg white hydrolysates obtained from 
chymotrypsin hydrolysis on 16.5% gel concentration. First three lanes from left represent 
Markers (Mol. wt. mentioned to the right of bands in kDa). EW: egg white (1%) solution 
in water; Chy1 (0.125 %) and Chy2 (1.25 %): chymotrypsin solution in water; PD (0, 4, 
8, 12, 18 and 24): egg white protein digest at different time points during 24 h hydrolysis 
with chymotrypsin. 
 
 
 
Figure 4.2. Changes in SDS-PAGE pattern of egg white hydrolysates obtained from 
chymotrypsin hydrolysis on 10-20% gel concentration. First three lanes from left 
represent Markers (Mol. wt. mentioned to the right of bands in kDa). EW: egg white 
(1%) solution in water; Chy1 (0.125 %) and Chy2 (1.25 %): chymotrypsin solution in 
water; PD (0, 4, 8, 12, 18 and 24): egg white protein digest at different time points during 
24 h hydrolysis with chymotrypsin. 
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Figure 4.3. Changes in SDS-PAGE pattern of egg white hydrolysates obtained from 
trypsin hydrolysis on 16.5% gel concentration. First three lanes from left represent 
Markers (Mol. wt. mentioned to the right of bands in kDa). EW: egg white (1%) solution 
in water; try1 (0.025 %) and tryt2 (0.25 %): trypsin solution in water; PD (0, 4, 8, 12 and 
24): egg white protein digest at different time points during 24 h hydrolysis with trypsin. 
 
Figure 4.4. Changes in SDS-PAGE pattern of egg white hydrolysates obtained from 
trypsin hydrolysis on 10-20% gel concentration. First three lanes from left represent 
Markers (Mol. wt. mentioned to the right of bands in kDa). try1 (0.025 %) and tryt2 (0.25 
%): trypsin solution in water; PD (0, 4, 8, 12 and 24): egg white protein digest at different 
time points during 24 h hydrolysis with trypsin. 
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                Figure 4.5. Changes in pH values during egg white hydrolysates preparation  
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          Figure 4.6. Survival of C. perfringens in egg white hydrolysates preparation using 
trypsin 
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 Figure 4.7. Survival of C. perfringens in egg white hydrolysates preparation using   
chymotrypsin 
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Figure 4.8. Survival of B. cereus in egg white hydrolysates preparation using trypsin 
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Figure 4.9. Survival of B. cereus in egg white hydrolysates preparation using 
chymotrypsin 
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CHAPTER V 
SUMMARY AND RECOMMENDATIONS 
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In the first part of the research, the dynamic model for the growth of Salmonella spp. in 
liquid whole egg was developed and validated. Additional research can be done in 
direction of developing dynamic growth predicting models for different blended egg 
products. Also, the validation of present dynamic model can be done for real time profiles 
followed by various food or egg processors.  
In the second part of the research, risk associated with egg white hydrolysates 
manufacturing process was evaluated for spore formers like B. cereus and C. perfringens. 
This study clearly showed that under optimal conditions of enzymes like chymotrypsin 
followed for egg white hydrolysis can result in favorable conditions for certain pathogens 
to grow. Further the effect of pH change in liquid whole egg on the growth of B. cereus 
can be studied. Also the peptides obtained during egg white hydrolysis can be analysed 
further for their ACE-inhibitory activity. Other enzymes can also be analyzed for their 
ability to hydrolyse egg white protein. 
The presence of toxins produced by B. cereus can also be studied to evaluate the safety of 
egg white hydrolysates against toxins and its rate of production. The thermal treatment 
involved during inactivation of enzymes (100
o
C/15 min) can kill spores or vegetative 
cells of spore formers but is ineffective to destroy toxins produced by these organisms. 
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A.1. A sample SAS code for fitting the growth data of Salmonella spp. in the 
Baranyi model at 37°C 
data egg37; 
input t logy; 
CFU = 10**logy; 
lny=log(CFU); 
datalines; 
0 2.322219295 
2 2.653212514 
4 3.51851394 
6 3.579783597 
8 4.431363764 
10 5.62324929 
12 6.812913357 
14 8.190331698 
16 8.301029996 
18 9.041392685 
20 8.740362689 
22 8.77815125 
24 8.812913357 
0 2.431363764 
2 2.86923172 
4 3.139879086 
6 3.255272505 
8 3.755874856 
10 5.77815125 
12 6.681241237 
14 7.544068044 
16 8.322219295 
18 8.792391689 
20 8.698970004 
25.5 8.86332286 
; 
title "Baranyi fitting"; 
proc nlin data=egg37 method=marquardt; 
parms yo=5.45 ymax=20.2 mumax=1.31 h0=5.26; 
 
model lny=yo+mumax*t+log(exp(-mumax*t)+exp(-h0)-exp(-mumax*t-h0))-
log(1+(exp(mumax*t+log(exp(- 
          mumax*t)+exp(-h0)-exp(-mumax*t-h0)))-1)/(exp(ymax-yo))); 
output out=baranyimodel30 parms=yo ymax mumax h0 p=predbar r=residbar; 
run 
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A.2. Code for fitting the growth data of Salmonella spp. in the Baranyi model at 
37°C after fixing ho 
data egg37; 
input t logy; 
CFU = 10**logy; 
lny=log(CFU); 
datalines; 
0 2.322219295 
2 2.653212514 
4 3.51851394 
6 3.579783597 
8 4.431363764 
10 5.62324929 
12 6.812913357 
14 8.190331698 
16 8.301029996 
18 9.041392685 
20 8.740362689 
22 8.77815125 
24 8.812913357 
0 2.431363764 
2 2.86923172 
4 3.139879086 
6 3.255272505 
8 3.755874856 
10 5.77815125 
12 6.681241237 
14 7.544068044 
16 8.322219295 
18 8.792391689 
20 8.698970004 
25.5 8.86332286 
; 
title "Baranyi fitting"; 
proc nlin data=egg37 method=marquardt; 
parms yo=6.34 ymax=20.23 mumax=1.31; h0=3.51; 
model lny=yo+mumax*t+log(exp(-mumax*t)+exp(-h0)-exp(-mumax*t-h0))-
log(1+(exp(mumax*t+log(exp(- 
          mumax*t)+exp(-h0)-exp(-mumax*t-h0)))-1)/(exp(ymax-yo))); 
output out=baranyimodel30 parms=yo ymax mumax h0 p=predbar r=residbar; 
run; 
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A.3. SAS code for fitting the maximum specific growth rates in the modified 
Ratkowsky equation 
data secondary; 
input T mu; 
sqmu = sqrt(mu); 
datalines; 
10 0.04 
15 0.15 
20 0.32 
25 0.506 
30 0.83 
35 1.12 
37 1.315 
39 1.23 
41 1.01 
43 0.8 
; 
title "ratkowsky-Bara"; 
proc nlin data=secondary method=marquardt; 
parms b = 0.0218 Tmin = 10 Tmax = 43 c=1; 
model mu=b*((T-Tmin)**2)*(1-exp(c*(T-Tmax))); 
output out=fullmodel parms=b c Tmin Tmax p=predfull r=resifull; 
run; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
135 
 
A.4. Example of the MATLAB codes for Ratkowsky-Baranyi dynamic model 
t = 0:15:20*60; 
T = (17.5*sin(2*pi.*t/(4*60)))+27.5; 
Tempvec = [t' T']; 
primod = [2.63, 8.35, 1.7788]; 
secmod = [2.8988, 47.6981, 0.00164, 0.3706] 
out = baranyi_dyn(Tempvec, secmod, primod) 
  
 
function out = baranyi_dyn(Tempvec, secmod, primod) 
  
% time - time vector in minutes 
% temp - temperature vector in degrees celcius 
% Secondary model: mu = a(T-Tmin)^2. (1-exp(b(T-Tmax))) 
% a, b, Tmin, and Tmax are parameters of the secondary model 
% yo - initial innoculum value in log(CFU/g) 
% ymax - maximum microbial population in log (CFU/g) 
% h - paremeter in the Baranyi model. 
close all 
clc; 
TIME_min = Tempvec(:, 1); 
Temp_C = Tempvec (:, 2); 
  
Tmin_C = secmod(1); 
Tmax_C = secmod(2); 
a = secmod(3); 
b = secmod(4); 
y0 = primod(1); 
ymax = primod(2); 
h0 = primod(3); 
  
clc; 
  
% Define Time Step 
dt_min = 15; 
dth = dt_min/60; 
  
% Create time vector - user input - it is assumed in uniform time steps 
  
t = TIME_min/60; 
 
nt = length(t); 
tt = [t(1):dth:t(nt)]; 
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csT = spline(t,Temp_C); 
TT = ppval(csT,tt); 
   
n = length(TT); 
tfinal = tt(n) 
   
% SOLVE DYNAMIC BARANYI'S MODEL USING RUNGE-KUTTA 4th ORDER  
  
% Spline interpolation of temperature to obtain midpoints of each time interval 
% Oversampling the time and temperature vectors by a factor of two for 
% calculation purposes 
  
csT = spline(tt,TT); 
t1 = [t(1):dth/2:tfinal]; % new time vector containing midpoint values 
T1 = ppval(csT,t1)  % new temperature vector containing midpoint values 
nn = length(t1); 
  
% Discretized Secondary Model 
% secondary model predicts growth rate as a function of temperature 
% determine the growth rate for the oversampled temperature vector. 
  
% initialize growth rate vector 
mumax = [];  
  
  for i = 1:length(T1) 
     if T1(i) > Tmax_C 
         mumax(i) = 0; 
     elseif T1(i) >= Tmin_C  
          mumax(i) = a*(T1(i) - Tmin_C)^2*(1-exp(b*(T1(i) - Tmax_C))); 
     elseif T1(i) < Tmin_C 
         mumax(i) = 0; 
     end 
  end 
  
% Numerical Solution of dQ/dt using RK4 
% Define Initial Condition 
  
% "work to be done", constant for given microorganism & given substrate 
% h0 = 1.7788;   
 
 
alpha = exp(-h0)           % initial physiological state of cells 
q0 = 1/(exp(h0)-1);        % initial bottleneck substance 
Q = []; 
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Q(1) = log(q0);            % initial condition for dQ/dt 
 
 
% Runge-Kutta algorithm 
i = 1; 
for j = 2:n 
  
% PREDICTION 
k1 = dth*(mumax(i)); 
k2 = dth*(mumax(i+1)); 
k3 = dth*(mumax(i+1)); 
k4 = dth*(mumax(i+2)); 
i = i+2; 
  
% CORRECTION 
Q(j) = Q(j-1) + ((1/6)*(k1 + (2*k2) + (2*k3) + k4)); 
end 
  
% Numerical Solution of dy/dt using RK4 
% Define Initial Condition 
  
y = []; 
y(1) = log(10^y0); % initial condition for dy/dt - user input 
  
% Define Maximum Cell Population - constant for given microorganism 
% & given substrate.   
  
ymax = log(10^ymax); 
  
% Spline interpolation of Q to obtain midpoints of each time interval 
% Oversample or increase the length of Q vector by a factor of two 
  
csQ = spline(tt,Q); 
t1 = [t(1):dth/2:tfinal]; % new time vector containing midpoint values 
QQ = ppval(csQ,t1);       % new Q vector containing midpoint values 
 
 
% Runge-Kutta algorithm 
i = 1; 
for j = 2:n 
  
% PREDICTION 
k1 = dth*(mumax(i)*(1/(1+exp(-QQ(i))))*(1-exp(y(j-1)-ymax))); 
k2 = dth*(mumax(i+1)*(1/(1+exp(-QQ(i+1))))*(1-exp((y(j-1)+(k1/2))- 
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     ymax))); 
k3 = dth*(mumax(i+1)*(1/(1+exp(-QQ(i+1))))*(1-exp((y(j-1)+(k2/2))- 
     ymax)));     
k4 = dth*(mumax(i+2)*(1/(1+exp(-QQ(i+2))))*(1-exp((y(j-1)+(k3))- 
     ymax))); 
i = i+2; 
       
% CORRECTION 
y(j) = y(j-1) + ((1/6)*(k1 + (2*k2) + (2*k3) + k4));     
end 
 
ypred = y./log(10); 
out = [tt' ypred']; 
 
% FIGURE 
figure, plotyy(tt,ypred,tt,TT); 
grid on 
xlabel('Time (h)') 
ylabel('log(CFU)/mL') 
title ('Time (h), Temp (C), log (CFU)/mL') 
 
